Professor Phil Hansbro

Professor Phil Hansbro

Professor, NHMRC Fellow and Brawn Fellow

School of Biomedical Sciences and Pharmacy (Immunology and Microbiology)

Of mice and mending

Professor Phil Hansbro is unconventional but effective, employing a number of experimental mouse models to investigate – and manipulate – the hallmark features of respiratory disease.

Professor Phil Hansbro

Hansbro's plan of attack on the diseases of our airways is quite simple – understand their pathogenesis to identify new avenues of therapy. Equal parts scientific and artistic, the ambitious academic's two-pronged approach is recognised internationally as a valuable, ongoing contribution to the field, affording researchers the opportunity to dissect and study the intricate architecture of multiple chronic inflammation disorders.

'Examining their development in humans is expensive and labour intensive,' he concedes.

'People can smoke for 10, 25, 50 years before they get emphysema.'

'Inducing them in laboratory mice, which are inbred and so identical, means that our work is well controlled.'

'We can be specific about the things we test for and find.'

The integration of molecular biology theory and practice, these novel models allow Hansbro and his team to explore respiratory disease and infection from several cellular angles. With expertise and particular emphasis on immunity, physiology and lung function analysis, their simulations of key pathogenic events excite those both in and out of the laboratory.

'Our research outcomes have a translational goal,' Hansbro explains.

'We aim to show that what we discover is important for human diseases too.'

Similarly acknowledging the importance of sticking to a realistic timeframe, the Hunter Medical Research Institute innovator employs both short-term and long-term studies.

'We're focused on identifying potential treatments for severe asthma and chronic obstructive pulmonary disease (COPD), also known as emphysema,' he declares.

'Existing treatments only partially suppress exacerbations and some don't work at all.'

'Sufferers are more susceptible to respiratory infections too, so we need to work out why this is and find ways to manage them – or better yet – prevent this co-morbidity altogether.'

Dynamic networks

Taking a 'very roundabout route' to get to this point, Hansbro began his research career in organic chemistry. The English native completed a PhD in the discipline at the University of Leeds in the early 90s, principally using it to investigate intracellular signalling pathways relevant to cancer.

'This involved isolating enzymes and using them to make compounds to produce biomembranes that release molecules, which when over-produced, are important in cancer,' he instructs.

The energetic scholar then headed across the ocean to Australia to undertake post-doctoral studies into protein biochemistry.  Also involving elements of microbiology and molecular biology, this endeavour inspired a widening of research fields and goals.

'This allowed us to explore the functions of these and other enzymes and molecules involved in muscle disease and respiration in some depth,' he states.

After these studies he moved back to England, taking up residency at the University of Cambridge in 1997 to design and test new vaccines against infection with the bacteria Streptococcus pneumoniae. The three-year appointment proved to be a mix of new and old for Hansbro, piquing his scientific curiosity in airway inflammation while also enabling him to continue using a range of microbiological and molecular techniques.

'Streptococcus pneumoniae is a major respiratory pathogen,' he reveals.

'It is the commonest cause of pneumonia and is also an important inducer of meningitis, blood and ear infections.'

Hansbro continued exploring the pathogenic bacterium after being recruited to the University of Newcastle, Australia, in the late 90s, impressively identifying a number of factors that protect against asthma. Developing them into therapeutic strategies for the last 15 years, the research leader is set to go into clinical trials with them 'some time' in 2015.

Gut reaction

In a simultaneous attempt to produce novel treatments for other respiratory diseases, Hansbro is conducting an extensive series of studies of the lower respiratory tract. The immunologist is investigating the role of inflammatory features and immune cells involved in the disease and is hoping his studies will help firm up understanding of the pathogenesis of COPD.

'In some experiments we're trying to determine the bacterial changes that occur in the lung and gut during the development of COPD,' he clarifies.

'So far we've found that smoking can alter the bacteria that make up the microbiome in the gut.'

'It also might be possible to 'drown out' emphysema-related bacteria using faecal transplants.'

Comically labelled 'transpoosion,' the unsavoury science involves taking faeces from healthy mice and putting them in the guts of those with COPD. No laughing matter though, this 'repoopulation' remedy may treat the symptoms of the disorder and/or protect against its development.

'We're in the process of studying bacteria that may be involved and discovering exactly what they do and what they are,' Hansbro divulges.

'The idea is that we'll eventually be able to develop new antibiotics or other therapies against them.'

Damage control

A master of many disciplines, Hansbro is concurrently running an experimental trial of epigenetic inhibitors. Acknowledging the increased production of inflammatory genes when people are overexposed to smoke and air pollution, the esteemed educator and investigator is looking to find ways to prevent harmful DNA modifications from occurring.

'Nicotine-induced acetylation causes DNA to unravel, which means it opens up more and allows enzymes to generate greater amounts of these genes,' he explains.

'We're looking at ways of stopping this in mice.'

'Then we can try to work out precisely how the inhibitors suppress disease.'

Exploring the possibilities of therapeutic gene silencing inherent in another form of epigenetics, Hansbro is also in the middle of specifying the function of microRNAs. Once thought to be junk byproducts of RNA, these small pieces are now widely thought to serve as on/off switches for inflammation.

'Some of them potentially target and destroy anti-inflammatory factors,' he claims.

'Knowing exactly how and why they're implicated in respiratory disease will help us to develop effective inhibitors.'

With oxidative stress from smoking similarly linked to pro-inflammatory environments, Hansbro is undertaking a research project on cellular respiration as well.

'We need to work out how mitochondria become altered to produce it,' he asserts.

'Then we can develop inhibitors.'

Two diseases, one knockout blow

Other new therapeutic targets for COPD are being imagined using a system of elimination, with Hansbro and his team 'knocking out' a number of genes in mast cells to infer probable function and identify novel roles. Observing physiological variances between wild mice and the mice that are deficient in particular factors, their current research implicates mast cells as pathological mediators of several inflammatory conditions.

'Our recent studies show knocking out two different genes causes the mice to get less COPD,' he affirms.

'This tells us how important they are in the disorder.'

Hansbro is also using the mice to explore and understand the pathogenesis of lung cancer. One-upping previous experimental models of the disease, which induce lung cancer in tissues in 9 months, the expert has got it down to just sixteen weeks.

'But we're hoping to cut that time in half,' he shares.

'We can find good treatments for lung cancer if we're aware of how it develops.'

The next phase

Set to translate this research into practice, Hansbro is looking forward to applying his therapies to humans.

'Proving their effectiveness takes a long time,' he admits.

'Once we're sure, we can start exposing our own respiratory cells to allergens or cigarette smoke and using the treatments to suppress elevated inflammatory responses.'

The Associate Director of the University's Priority Research Centre for Healthy Lungs is similarly looking forward to celebrating the achievements of his young collaborators at the Hunter Medical Research Institute.

'We really believe in our students and early career researchers,' he avows.

'They're the next generation of scientists.'

More about Phil's Career

Related links

Professor Phil Hansbro

Of mice and mending

and infections and is developing interests in lung cancer.

Read more

Career Summary

Biography

Professor Phil Hansbro is an internationally recognised research leader in the study of respiratory diseases, such as asthma, chronic obstructive airway disease (COPD, aka emphysema) and infections and is developing interests in lung cancer. His work is substantially contributing to understanding the pathogenesis and developing new therapies for these diseases. Indeed his work has made internationally important contributions and led to the identification of novel avenues for therapy that are under further study. This is achieved through the development of novel mouse models that recapitulate the hallmark features of human disease, including infections, asthma and COPD and now lung cancer. He employs these models in integrated approaches (infection, immunity & physiology with particular expertise in lung function analysis) to understand human diseases, and develop new treatment strategies. Research outcomes have a translational goal and his studies are conducted in parallel with collaborative human studies with clinical researchers. Major achievements:

1. Identified that the age, timing and nature of infection is critical in determining effects on asthma.

2. Determined that Chlamydia infection induces severe asthma in early life and adults.

3. Showed that combination of Haemophilus influenzae or Chlamydia respiratory infection and asthma drives a severe steroid-resistant asthma phenotype and chronic infection in adults.

4. Showed that Streptococcus pneumoniae exposure is protective against asthma.

5. Identified potential novel asthma therapeutic strategies that either target or utilise bacteria.

6. Created a short-term mouse model of COPD with the hallmark features of the human disease.

7. Identified novel roles for mast cell tryptases in experimental COPD.

8. Demonstrated critical roles for constitutive IFN responses and viral proteins in influenza.

9. Discovered that a new interferon, IFNε, protects against Chlamydia reproductive tract infection.

10. Developed a novel model of lung cancer that is induced by cigarette smoke.

11. He is also an expert in the study of avian influenza viruses (AIVs) in wild birds and to date his group has collected over 240,000 samples and identified ~250 AIVs.

His group has been recognized by the award of numerous nationally competitive grants, particularly from the NHMRC. Since 2004 he has published ~100 peer reviewed journal articles, with an average impact factor of 5+. These include publications in the leading general (Science [IF=31], Nature Immunology [IF=26]), respiratory (Am J Respir Crit Care Med [IF=12]), allergy (J Allergy Clin Immunol [IF=11]), infection (PLoS Pathog [IF=9]) and immunology journals (J Immunol [IF=6]). He is frequently invited to write reviews in prestigious journals (Pharmacol Ther [IF=8.0], Am J Respir Cell Mol Biol [IF=4.5], Immunology [IF=3.4]), which make substantial contributions to the fields. He is a regular reviewer for national granting bodies and leading international journals.

Prof Hansbro has a high level record of achievement & performance as a research leader recognised by high level appointments (Deputy director of the Centre for Asthma & Respiratory Disease (CARD) & the CRC for Asthma & Airways [CRCAA, UoN 2005-12], Head, Discipline of Immunology & Microbiology [2007-11], joint leader of Infection & Immunity Research Cluster, Director of School Research Committee). These Centres & Groups are internationally recognised for contributions to respiratory & infectious diseases. With Profs P. Foster & P. Gibson has built an internationally recognised, world leading research program with a reputation for excellence in respiratory research; CARD, with state-of-the-art facilities for the study of infection, immunity, histology, respiratory physiology & function.

Research Expertise
Expertise in the inevstigation of the relationship between bacterial and viral infections and obstructive airway diseases such as asthma and COPD. Expertise in the collection and analysis of avian influenza viruses from wild birds.

Teaching Expertise
Extensive undergraduate and postgraduate teaching experience into a wide variety of courses using teh full range of educational tools. Particular expertise in teaching Biomedical Sciences, Medicine, Nursing.

Administrative Expertise
Extensive expertise and experience in University administration and governance. head of Discipline of Immunology & Microbiology, Deputy Head of School of bIomedical Sciences Research Committee and various teaching administration bodies.



Qualifications

  • PhD, University of Leeds - UK
  • Bachelor of Science (Honours), Hallamshire University

Keywords

  • Allergy
  • Asthma
  • Avian influenza
  • Bacteriology
  • COPD
  • Epigenetics
  • Immunology
  • Infectious diseases
  • Inflammasome
  • Inflammation
  • Lung cancer
  • Microbiology
  • Microbiome
  • Reproductive tract diseases
  • Respiratory diseases
  • Virology

Fields of Research

Code Description Percentage
110299 Cardiorespiratory Medicine and Haematology not elsewhere classified 25
110799 Immunology not elsewhere classified 75

Professional Experience

UON Appointment

Title Organisation / Department
Professor University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia

Academic appointment

Dates Title Organisation / Department
Head - Discipline of Immunology & Microbiology University of Newcastle
Australia
Co-director Infection and Immunity Research Cluster University of Newcastle
School of Biomedical Sciences
Australia
Deputy Program Leader - Priority Research Centre for Asthma and Airways, UNEW University of Newcastle
Australia
1/07/2011 -  Professor University of Newcastle
Immunology & Microbiology
Australia
1/07/2007 - 1/06/2011 Associate Professor University of Newcastle
Immunology & Microbiology
Australia
1/01/2007 -  Head of Discipline of Immunology & Microbiology University of Newcastle
Australia
1/01/2005 - 31/12/2007 Organiser and Convenor - Newcastle Asthma Meeting University of Newcastle
Australia
1/01/2005 - 1/06/2007 Senior Lecturer University of Newcastle
Immunology & Microbiology
Australia
1/10/1999 -  Group leader Microbiology Research Group University of Newcastle
Australia
1/10/1999 - 1/12/2004 Lecturer in Microbiology University of Newcastle
Australia
1/10/1999 - 1/12/2004 Lecturer University of Newcastle
Immunology & Microbiology
Australia

Membership

Dates Title Organisation / Department
Membership - School of Biomedical Sciences Executive University of Newcastle
Australia
Member - Organising Committee of the International Symposium on Pneumococci and Pneumococcal Diseases Organising Committee of the International Symposium on Pneumococci and Pneumococcal Diseases
Australia
Invited Academic Member - Nuways Committee for Streamlining Research Processes University of Newcastle
Deputy Head School of Biomedical Sciences Research Committee
Australia
External Member - Mater Hospital Grant Review Panel Mater Hospital Grant Review Panel
Australia
Member - National Avian Influenza Stearing Committee National Avian Influenza Stearing Committee
Australia
Member - NHMRC Grant Review Panel (GRP2e inflammation) NHMRC Grant Review Panel
Australia
Associate Director - Priority Research Centre for Asthma and Airways, UNEW University of Newcastle
Australia
Representative of UNEW and HMRI nodes - CRC for Asthma and Airways Education Committee CRC for Asthma and Airways
Australia

Awards

Research Award

Year Award
2005 Brawn fellowship
University of Newcastle
2002 Leo Dintenfass Award
Rebecca L Cooper Medical Research Foundation Ltd

Invitations

External Reviewer - Programs

Year Title / Rationale
2006 research grants review panel
Organisation: Mater Hospital Description: research leader

Participant

Year Title / Rationale
2007 CRC for asthma and airways
Organisation: CRC for asthma and airways Description: Contribution to asthma research
2006 Influenza symposium
Organisation: Influenza symposium Description: Ledaer in bird flu research
2006 National avian influenza conference
Organisation: National avian influenza conference Description: Leader in influenza research
2006 Various including Asthma Think tank and a variety of other invited talks at departments and conferences
Organisation: Many Description: Resaerch leader in asthma
2006 CRC for asthma and airways
Organisation: CRC for asthma and airways Description: Contribution to asthma research
2005 CRC for asthma and airways
Organisation: CRC for asthma and airways Description: Contribution to asthma research
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (3 outputs)

Year Citation Altmetrics Link
2014 Hsu A, Zhong H, Hansbro P, Wark P, 'Innate Immunity in the Airways to Respiratory Viruses', Virology II - Advanced Issues, iConcept Press, Hong Kong 1-32 (2014) [B1]
Co-authors Peter Wark, Alan Hsu
2014 Hsu A, Loo S, Fathi Aghdam F, Parsons K, Hansbro P, Wark P, 'Airway Epithelial and Early Innate Immune Responses to Virus Infections', Human Respiratory Viral Infections, CRC Press, Boca Raton, FL 29-44 (2014) [B1]
DOI 10.1201/b16778-5
Co-authors Peter Wark, Alan Hsu
2010 Hansbro PM, 'Migratory birds at Hunter Valley Gardens', Beautiful Birds: From Hunter Valley Gardens, Panographs Publishing, Wamberal, NSW 47 (2010) [B2]

Journal article (150 outputs)

Year Citation Altmetrics Link
2016 Russell KE, Chung KF, Clarke CJ, Durham AL, Mallia P, Footitt J, et al., 'The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD.', PLoS One, 11 e0146102 (2016)
DOI 10.1371/journal.pone.0146102
Co-authors Malcolm Starkey
2016 Ren S, Hure A, Peel R, D'Este C, Abhayaratna W, Tonkin A, et al., 'Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)', American Heart Journal, 177 58-65 (2016)

© 2016 Elsevier, Inc.Background Research has shown that vaccination with Streptococcus pneumoniae reduced the extent of atherosclerosis in experimental animal models. It is thoug... [more]

© 2016 Elsevier, Inc.Background Research has shown that vaccination with Streptococcus pneumoniae reduced the extent of atherosclerosis in experimental animal models. It is thought that phosphorylcholine lipid antigens in the S. pneumoniae cell wall induce the production of antibodies that cross-react with oxidized low-density lipoprotein, a component of atherosclerotic plaques. These antibodies may bind to and facilitate the regression of the plaques. Available data provide evidence that similar mechanisms also occur in humans, leading to the possibility that pneumococcal vaccination protects against atherosclerosis. A systematic review and meta-analysis, including 8 observational human studies, of adult pneumococcal polysaccharide vaccination for preventing cardiovascular disease in people older than 65 years, showed a 17% reduction in the odds (odds ratio 0.83, 95% CI 0.71-0.97) of having an acute coronary syndrome event. Methods/Design The AUSPICE is a multicenter, randomized, placebo-controlled, double-blind, clinical trial to formally test whether vaccination with the pneumococcal polysaccharide vaccine protects against cardiovascular events (fatal and nonfatal acute coronary syndromes and ischemic strokes). Cardiovascular outcomes will be obtained during 4 to 5 years of follow-up, through health record linkage with state and national administrative data sets. Conclusion This is the first registered randomized controlled trial (on US, World Health Organization, Australia and New Zealand trial registries) to be conducted to test whether vaccination with the pneumococcal polysaccharide vaccine will reduce cardiovascular events. If successful, vaccination can be readily extended to at-risk groups to reduce the risk of cardiovascular diseases.

DOI 10.1016/j.ahj.2016.04.003
Co-authors Chris Levi, David Durrheim, Mark Mcevoy, Alexis Hure, John Attia
2016 Camlin NJ, Sobinoff AP, Sutherland JM, Beckett EL, Jarnicki AG, Vanders RL, et al., 'Maternal Smoke Exposure Impairs the Long-Term Fertility of Female Offspring in a Murine Model.', Biol Reprod, 94 39 (2016)
DOI 10.1095/biolreprod.115.135848
Citations Scopus - 1
Co-authors Jessie Sutherland, Eileen Mclaughlin
2016 Simpson JL, Baines KJ, Horvat JC, Essilfie AT, Brown AC, Tooze M, et al., 'COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species', Respirology, 21 697-704 (2016) [C1]

© 2016 Asian Pacific Society of Respirology.Background and objective Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and inflammat... [more]

© 2016 Asian Pacific Society of Respirology.Background and objective Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and inflammation. Airway bacterial colonization is increased in COPD; however, the role of potentially pathogenic and non-pathogenic bacteria in the pathogenesis of disease is unclear. This study characterized the presence of bacteria in a well-characterized cohort of adults with COPD and healthy controls. Methods Adults with COPD (n = 70) and healthy controls (n = 51) underwent clinical assessment and sputum induction. Sputum was dispersed, and total and differential cell counts were performed. Bacteria were cultured, identified and enumerated. Supernatants were assessed for neutrophil elastase (NE) and IL-1ß. Common respiratory pathogens were also determined using real-time PCR. Results Participants with COPD had a typical neutrophilic inflammatory profile. The total load of bacteria was increased in COPD and was associated with poorer respiratory health status, as measured by the St George's Respiratory Questionnaire (Spearman's r = 0.336, P = 0.013). Significantly lower levels of culturable Bacillus species were identified compared with healthy controls. PCR analyses revealed increased rates of detection of potentially pathogenic bacteria with Haemophilus influenzae detection associated with higher sputum levels of NE and IL-1ß, while Streptococcus pneumoniae was more common in male ex-smokers with emphysema and a deficit in diffusion capacity. Conclusion Non-pathogenic and pathogenic bacteria were altered in the sputum of patients with COPD. These observations highlight the potential to identify treatment and management strategies that both target specific bacterial pathogens and restore the microbial balance, which may lead to reductions in inflammation and subsequent improvements in lung health.

DOI 10.1111/resp.12734
Co-authors Jodie Simpson, Peter Gibson, Jay Horvat, Vanessa Mcdonald, Katherine Baines
2016 Hansbro P, Nair P, Starkey M, Haw T, Liu G, Clark A, Ammit A, 'TRISTETRAPROLIN PROTECTS MICE AGAINST CIGARETTE-SMOKE INDUCED EXPERIMENTAL COPD', RESPIROLOGY, 21 125-125 (2016)
2016 Haw TJ, Starkey MR, Nair PM, Pavlidis S, Liu G, Nguyen DH, et al., 'A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease', Mucosal Immunology, 9 859-872 (2016) [C1]

Chronic obstructive pulmonary disease (COPD) is a life-Threatening inflammatory respiratory disorder, often induced by cigarette smoke (CS) exposure. The development of effective ... [more]

Chronic obstructive pulmonary disease (COPD) is a life-Threatening inflammatory respiratory disorder, often induced by cigarette smoke (CS) exposure. The development of effective therapies is impaired by a lack of understanding of the underlining mechanisms. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine with inflammatory and apoptotic properties. We interrogated a mouse model of CS-induced experimental COPD and human tissues to identify a novel role for TRAIL in COPD pathogenesis. CS exposure of wild-Type mice increased TRAIL and its receptor messenger RNA (mRNA) expression and protein levels, as well as the number of TRAIL + CD11b + monocytes in the lung. TRAIL and its receptor mRNA were also increased in human COPD. CS-exposed TRAIL-deficient mice had decreased pulmonary inflammation, pro-inflammatory mediators, emphysema-like alveolar enlargement, and improved lung function. TRAIL-deficient mice also developed spontaneous small airway changes with increased epithelial cell thickness and collagen deposition, independent of CS exposure. Importantly, therapeutic neutralization of TRAIL, after the establishment of early-stage experimental COPD, reduced pulmonary inflammation, emphysema-like alveolar enlargement, and small airway changes. These data provide further evidence for TRAIL being a pivotal inflammatory factor in respiratory diseases, and the first preclinical evidence to suggest that therapeutic agents that target TRAIL may be effective in COPD therapy.

DOI 10.1038/mi.2015.111
Co-authors Darryl Knight, Alan Hsu, Paul Foster, Peter Wark, Jay Horvat, Joerg Mattes, Malcolm Starkey
2016 Conickx G, Mestdagh P, Avila Cobos F, Verhamme FM, Maes T, Vanaudenaerde BM, et al., 'MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease.', Am J Respir Crit Care Med, (2016)
DOI 10.1164/rccm.201506-1182OC
Co-authors Alan Hsu
2016 Hsu AC, Parsons K, Moheimani F, Knight DA, Hansbro PM, Fujita T, Wark PA, 'Impaired Antiviral Stress Granule and IFN-ß Enhanceosome Formation Enhances Susceptibility to Influenza Infection in Chronic Obstructive Pulmonary Disease Epithelium.', Am J Respir Cell Mol Biol, 55 117-127 (2016)
DOI 10.1165/rcmb.2015-0306OC
Co-authors Darryl Knight, Alan Hsu, Fatemeh Moheimani
2016 Thorburn AN, Tseng HY, Donovan C, Hansbro NG, Jarnicki AG, Foster PS, et al., 'TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD.', PLoS One, 11 e0156402 (2016)
DOI 10.1371/journal.pone.0156402
Co-authors Peter Gibson, Paul Foster
2016 Tang FS, Hansbro PM, Burgess JK, Ammit AJ, Baines KJ, Oliver BG, 'A novel immunomodulatory function of neutrophils on rhinovirus-activated monocytes in vitro.', Thorax, (2016)
DOI 10.1136/thoraxjnl-2015-207781
Co-authors Katherine Baines
2016 Rahman MM, Rumzhum NN, Hansbro PM, Morris JC, Clark AR, Verrills NM, Ammit AJ, 'Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells', Cellular Signalling, 28 325-334 (2016) [C1]

© 2016.Chronic respiratory diseases are driven by inflammation, but some clinical conditions (severe asthma, COPD) are refractory to conventional anti-inflammatory therapies. Thu... [more]

© 2016.Chronic respiratory diseases are driven by inflammation, but some clinical conditions (severe asthma, COPD) are refractory to conventional anti-inflammatory therapies. Thus, novel anti-inflammatory strategies are necessary. The mRNA destabilizing protein, tristetraprolin (TTP), is an anti-inflammatory molecule that functions to induce mRNA decay of cytokines that drive pathogenesis of respiratory disorders. TTP is regulated by phosphorylation and protein phosphatase 2A (PP2A) is responsible for dephosphorylating (and hence activating) TTP, amongst other targets. PP2A is activated by small molecules, FTY720 and AAL(S), and in this study we examine whether these compounds repress cytokine production in a cellular model of airway inflammation using A549 lung epithelial cells stimulated with tumor necrosis factor a (TNFa) in vitro. PP2A activators significantly increase TNFa-induced PP2A activity and inhibit mRNA expression and protein secretion of interleukin 8 (IL-8) and IL-6; two key pro-inflammatory cytokines implicated in respiratory disease and TTP targets. The effect of PP2A activators is not via an increase in TNFa-induced TTP mRNA expression; instead we demonstrate a link between PP2A activation and TTP anti-inflammatory function by showing that specific knockdown of TTP with siRNA reversed the repression of TNFa-induced IL-8 and IL-6 mRNA expression and protein secretion by FTY720. Therefore we propose that PP2A activators affect the dynamic equilibrium regulating TTP; shifting the equilibrium from phosphorylated (inactive) towards unphosphorylated (active) but unstable TTP. PP2A activators boost the anti-inflammatory function of TTP and have implications for future pharmacotherapeutic strategies to combat inflammation in respiratory disease.

DOI 10.1016/j.cellsig.2016.01.009
Co-authors Nikki Verrills
2016 Ormerod KL, Wood DL, Lachner N, Gellatly SL, Daly JN, Parsons JD, et al., 'Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals.', Microbiome, 4 36 (2016)
DOI 10.1186/s40168-016-0181-2
2016 Gang L, Hsu A, Cooley MA, Jarnicki AG, Nair PM, Haw TJ, et al., 'Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases', Journal of Clinical Investigation Insight, 1 (2016)
DOI 10.1172/jci.insight.86380
Co-authors Jay Horvat, Michael Fricker, Peter Wark, Alan Hsu, Darryl Knight, Marjorie Walker
2016 Starkey M, Nguyen D, Kim R, Haw T, Nair P, Essilfie A, et al., 'EARLY-LIFE RESPIRATORY BACTERIAL INFECTION-INDUCED CHRONIC LUNG DISEASE IS DRIVEN BY A NOVEL TLR2/IL-13/MIR-21/PI3K SIGNALLING PATHWAY', RESPIROLOGY, 21 37-37 (2016)
Co-authors Jay Horvat
2016 Kim R, Pinkerton J, Essilfie A, Robertson A, Baines K, Mayall J, et al., 'NLRP3 INFLAMMASOME- MEDIATED, IL-1 beta-DEPENDENT INFLAMMATORY RESPONSES DRIVE SEVERE, STEROID-INSENSITIVE ASTHMA', RESPIROLOGY, 21 46-46 (2016)
Co-authors Jay Horvat, Peter Gibson, Peter Wark
2016 Hansbro P, Brown A, Essilfie A, Beckett E, Thorburn A, Hansbro N, et al., 'PROGRAMMED DEATH-1 (PD-1) PREDISPOSES TO RESPIRATORY VIRAL INFECTION-INDUCED SECONDARY BACTERIAL PNEUMONIA', RESPIROLOGY, 21 58-58 (2016)
Co-authors Jay Horvat
2016 Starkey M, Haw T, Pavlidis S, Nair MP, Liu G, Hanish I, et al., 'TOLL-LIKE RECEPTOR 7 PROMOTES CIGARETTE-SMOKE INDUCED EMPHYSEMA-LIKE ALVEOLAR ENLARGEMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE', RESPIROLOGY, 21 79-79 (2016)
Co-authors Jay Horvat
2016 Pinkerton J, Kim R, Essilfie A, Rae B, Mayall J, Ali M, et al., 'TARGETING OXIDATIVE STRESS FOR THE SUPPRESSION OF SEVERE, STEROID-INSENSITIVE ASTHMA', RESPIROLOGY, 21 105-105 (2016)
Co-authors Jay Horvat
2016 Gold MJ, Hiebert PR, Park HY, Stefanowicz D, Le A, Starkey MR, et al., 'Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization.', Mucosal Immunol, 9 809-820 (2016)
DOI 10.1038/mi.2015.104
Citations Scopus - 1
Co-authors Malcolm Starkey, Jay Horvat, Darryl Knight
2016 Hansbro P, Sunkara K, Jarnicki A, Kim R, Haw T, Wark P, et al., 'ROLE OF MIR-21 IN THE PATHOGENESIS OF EXPERIMENTAL COPD', RESPIROLOGY, 21 125-125 (2016)
Co-authors Jay Horvat, Peter Wark
2016 Moores N, Rogers DI, Rogers K, Hansbro PM, 'Reclamation of tidal flats and shorebird declines in Saemangeum and elsewhere in the Republic of Korea', Emu, 116 136-146 (2016)

© BirdLife Australia 2016.Saemangeum, in the Republic of Korea (ROK, commonly called South Korea) was one of the most important shorebird staging sites in the Yellow Sea. It supp... [more]

© BirdLife Australia 2016.Saemangeum, in the Republic of Korea (ROK, commonly called South Korea) was one of the most important shorebird staging sites in the Yellow Sea. It supported at least 330000 shorebirds annually between 1997 and 2001, including ~30% of the world population of Great Knots (Calidris tenuirostris) during both northward and southward migration. Construction of a 33-km long sea-wall was completed in April 2006. We show that shorebird numbers at Saemangeum and two adjacent wetlands decreased by 130000 during northward migration in the next two years and that all species have declined at Saemangeum since completion of the sea-wall. Great Knots were among the most rapidly affected species. Fewer than 5000 shorebirds were recorded at Saemangeum during northward migration in 2014. We found no evidence to suggest that most shorebirds of any species displaced from Saemangeum successfully relocated to other sites in the ROK. Instead, by 2011-13 nearly all species had declined substantially in the ROK since previous national surveys in 1998 and 2008, especially at more heavily reclaimed sites. It is likely that these declines were driven by increased mortality rather than movement to alternate staging sites given that other studies have shown concurrent declines in numbers and survival on the non-breeding grounds. This is the first study in the East Asian-Australasian Flyway to confirm declines of shorebirds at a range of geographical scales following a single reclamation project. The results indicate that if migratory shorebirds are displaced from major staging sites by reclamation they are probably unable to relocate successfully to alternate sites.

DOI 10.1071/MU16006
Citations Scopus - 3
2016 Starkey MR, Nguyen DH, Brown AC, Essilfie AT, Kim RY, Yagita H, et al., 'Programmed Death Ligand 1 Promotes Early-Life Chlamydia Respiratory Infection-Induced Severe Allergic Airway Disease.', Am J Respir Cell Mol Biol, 54 493-503 (2016)
DOI 10.1165/rcmb.2015-0204OC
Co-authors Jay Horvat, Malcolm Starkey
2015 Essilfie A, Horvat JC, Kim RY, Mayall JR, Pinkerton JW, Beckett EL, et al., 'Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma', Thorax Journal, 70 458-467 (2015) [C1]
DOI 10.1136/thoraxjnl-2014-206067
Citations Scopus - 12Web of Science - 2
Co-authors Jodie Simpson, Peter Gibson, Malcolm Starkey, Jay Horvat, Paul Foster
2015 Vanders RL, Murphy VE, Gibson PG, Hansbro PM, Wark PAB, 'CD8 T cells and dendritic cells: Key players in the attenuated maternal immune response to influenza infection', Journal of Reproductive Immunology, 107 1-9 (2015) [C1]

© 2014 Elsevier Ireland Ltd.Pregnancy provides a unique challenge for maternal immunity, requiring the ability to tolerate the presence of a semi-allogeneic foetus, and yet still... [more]

© 2014 Elsevier Ireland Ltd.Pregnancy provides a unique challenge for maternal immunity, requiring the ability to tolerate the presence of a semi-allogeneic foetus, and yet still being capable of inducing an immune response against invading pathogens. To achieve this, numerous changes must occur in the activity and function of maternal immune cells throughout the course of pregnancy. Respiratory viruses take advantage of these changes, altering the sensitive balance of maternal immunity, leaving the mother with increased susceptibility to viral infections and increased disease severity. Influenza virus is one of the most common respiratory virus infections during pregnancy, leading to an increased risk of ICU hospitalisations, pneumonia, acute respiratory distress syndrome and even death. Whilst much research has been performed to understand the changes that must take place in maternal immunity during pregnancy, considerable work is still needed to fully comprehend this tremendous feat. To date, few studies have focused on the alterations that occur in maternal immunity during respiratory virus infections. This review highlights the role of dendritic cells (DCs) and CD8 T cells during pregnancy, and the changes that occur in these antiviral cells following influenza virus infections.

DOI 10.1016/j.jri.2014.09.051
Citations Scopus - 2
Co-authors Peter Gibson, Vanessa Murphy, Peter Wark
2015 Griekspoor P, Hansbro PM, Waldenström J, Olsen B, 'Campylobacter jejuni sequence types show remarkable spatial and temporal stability in Blackbirds.', Infection ecology & epidemiology, 5 1-5 (2015) [C1]
DOI 10.3402/iee.v5.28383
2015 Zouikr I, Ahmed AF, Horvat JC, Beagley KW, Clifton VL, Ray A, et al., 'Programming of formalin-induced nociception by neonatal LPS exposure: Maintenance by peripheral and central neuroimmune activity', Brain, Behavior, and Immunity, 44 235-246 (2015) [C1]

© 2014.The immune and nociceptive systems are shaped during the neonatal period where they undergo fine-tuning and maturation. Painful experiences during this sensitive period of... [more]

© 2014.The immune and nociceptive systems are shaped during the neonatal period where they undergo fine-tuning and maturation. Painful experiences during this sensitive period of development are known to produce long-lasting effects on the immune and nociceptive responses. It is less clear, however, whether inflammatory pain responses are primed by neonatal exposure to mild immunological stimuli, such as with lipopolysaccharide (LPS). Here, we examine the impact of neonatal LPS exposure on inflammatory pain responses, peripheral and hippocampal interleukin-1ß (IL-1ß), as well as mast cell number and degranulation in preadolescent and adult rats. Wistar rats were injected with LPS (0.05 mg/kg IP, Salmonella enteritidis) or saline on postnatal days (PNDs) 3 and 5 and later subjected to the formalin test at PNDs 22 and 80-97. At both time-points, and one-hour after formalin injection, blood and hippocampus were collected for measuring circulating and central IL-1ß levels using ELISA and Western blot, respectively. Paw tissue was also isolated to assess mast cell number and degree of degranulation using Toluidine Blue staining. Behavioural analyses indicate that at PND 22, LPS-challenged rats displayed enhanced flinching (p<.01) and licking (p<.01) in response to formalin injection. At PNDs 80-97, LPS-challenged rats exhibited increased flinching (p<.05), an effect observed in males only. Furthermore, neonatal LPS exposure enhanced circulating IL-1ß and mast cell degranulation in preadolescent but not adult rats following formalin injection. Hippocampal IL-1ß levels were increased in LPS-treated adult but not preadolescent rats in response to formalin injection. These data suggest neonatal LPS exposure produces developmentally regulated changes in formalin-induced behavioural responses, peripheral and central IL-1ß levels, as well as mast cell degranulation following noxious stimulation later in life. These findings highlight the importance of immune activation during the neonatal period in shaping immune response and pain sensitivity later in life. This is of clinical relevance given the high prevalence of bacterial infection during the neonatal period, particularly in the vulnerable population of preterm infants admitted to neonatal intensive care units.

DOI 10.1016/j.bbi.2014.10.014
Citations Scopus - 3Web of Science - 1
Co-authors Rick Thorne, Deborah Hodgson, Jay Horvat
2015 Mateer SW, Maltby S, Marks E, Foster PS, Horvat JC, Hansbro PM, Keely S, 'Potential mechanisms regulating pulmonary pathology in inflammatory bowel disease.', J Leukoc Biol, 98 727-737 (2015) [C1]
DOI 10.1189/jlb.3RU1114-563R
Co-authors Paul Foster, Steven Maltby, Simon Keely, Jay Horvat
2015 Tay HL, Kaiko GE, Plank M, Li J, Maltby S, Essilfie AT, et al., 'Correction: Antagonism of miR-328 Increases the Antimicrobial Function of Macrophages and Neutrophils and Rapid Clearance of Non-typeable Haemophilus Influenzae (NTHi) from Infected Lung.', PLoS pathogens, 11 e1004956 (2015) [O1]
Citations Scopus - 2
Co-authors Steven Maltby, Paul Foster, Ming Yang, Joerg Mattes
2015 King PT, Sharma R, O'Sullivan K, Selemidis S, Lim S, Radhakrishna N, et al., 'Nontypeable Haemophilus influenzae Induces Sustained Lung Oxidative Stress and Protease Expression', PLOS ONE, 10 (2015) [C1]
DOI 10.1371/journal.pone.0120371
Citations Scopus - 1
2015 Moheimani F, Roth HM, Cross J, Reid AT, Shaheen F, Warner SM, et al., 'Disruption of ß-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair', International Journal of Biochemistry and Cell Biology, 68 59-69 (2015) [C1]

© 2015 Elsevier Ltd.The epithelium of asthmatics is characterized by reduced expression of E-cadherin and increased expression of the basal cell markers ck-5 and p63 that is indi... [more]

© 2015 Elsevier Ltd.The epithelium of asthmatics is characterized by reduced expression of E-cadherin and increased expression of the basal cell markers ck-5 and p63 that is indicative of a relatively undifferentiated repairing epithelium. This phenotype correlates with increased proliferation, compromised wound healing and an enhanced capacity to undergo epithelial-mesenchymal transition (EMT). The transcription factor ß-catenin plays a vital role in epithelial cell differentiation and regeneration, depending on the co-factor recruited. Transcriptional programs driven by the ß-catenin/CBP axis are critical for maintaining an undifferentiated and proliferative state, whereas the ß-catenin/p300 axis is associated with cell differentiation. We hypothesized that disrupting the ß-catenin/CBP signaling axis would promote epithelial differentiation and inhibit EMT. We treated monolayer cultures of human airway epithelial cells with TGFß1 in the presence or absence of the selective small molecule ICG-001 to inhibit ß-catenin/CBP signaling. We used western blots to assess expression of an EMT signature, CBP, p300, ß-catenin, fibronectin and ITGß1 and scratch wound assays to assess epithelial cell migration. Snai-1 and -2 expressions were determined using q-PCR. Exposure to TGFß1 induced EMT, characterized by reduced E-cadherin expression with increased expression of a-smooth muscle actin and EDA-fibronectin. Either co-treatment or therapeutic administration of ICG-001 completely inhibited TGFß1-induced EMT. ICG-001 also reduced the expression of ck-5 and -19 independent of TGFß1. Exposure to ICG-001 significantly inhibited epithelial cell proliferation and migration, coincident with a down regulation of ITGß1 and fibronectin expression. These data support our hypothesis that modulating the ß-catenin/CBP signaling axis plays a key role in epithelial plasticity and function.

DOI 10.1016/j.biocel.2015.08.014
Citations Scopus - 1
Co-authors Darryl Knight, Fatemeh Moheimani
2015 Baillet AC, Rehaume LM, Benham H, O'Meara CP, Armitage CW, Ruscher R, et al., 'High Chlamydia Burden Promotes Tumor Necrosis Factor-Dependent Reactive Arthritis in SKG Mice', ARTHRITIS & RHEUMATOLOGY, 67 1535-1547 (2015) [C1]
DOI 10.1002/art.39041
Citations Scopus - 2Web of Science - 1
2015 Hsu ACY, Starkey MR, Hanish I, Parsons K, Haw TJ, Howland LJ, et al., 'Targeting PI3K-p110a suppresses influenza virus infection in chronic obstructive pulmonary disease', American Journal of Respiratory and Critical Care Medicine, 191 1012-1023 (2015) [C1]

Copyright © 2015 by the American Thoracic Society.Rationale: Chronic obstructive pulmonary disease (COPD) and influenza virus infections are major global health issues. Patients ... [more]

Copyright © 2015 by the American Thoracic Society.Rationale: Chronic obstructive pulmonary disease (COPD) and influenza virus infections are major global health issues. Patients with COPD are more susceptible to infection, which exacerbates their condition and increases morbidity and mortality. The mechanisms of increased susceptibility remain poorly understood, and current preventions and treatments have substantial limitations. Objectives: To characterize the mechanisms of increased susceptibility to influenza virus infection in COPD and the potential for therapeutic targeting. Methods: We used a combination of primary bronchial epithelial cells (pBECs) from COPD and healthy control subjects, a mouse model of cigarette smoke-induced experimental COPD, and influenza infection. The role of the phosphoinositide-3-kinase (PI3K) pathway was characterized using molecular methods, and its potential for targeting assessed using inhibitors. Measurements and Main Results: COPDpBECs were susceptible to increased viral entry and replication. Infected mice with experimental COPD also had more severe infection (increased viral titer and pulmonary inflammation, and compromised lung function). These processes were associated with impaired antiviral immunity, reduced retinoic acid-inducible gene-I, and IFN/cytokine and chemokine responses. Increased PI3K-p110a levels and activity inCOPDpBECs and/or mice were responsible for increased infection and reduced antiviral responses. Global PI3K, specific therapeutic p110a inhibitors, or exogenous IFN-b restored protective antiviral responses, suppressed infection, and improved lung function. Conclusions: The increased susceptibility of individuals with COPD to influenza likely results from impaired antiviral responses, which are mediated by increased PI3K-p110a activity. This pathway may be targeted therapeutically in COPD, or in healthy individuals, during seasonal or pandemic outbreaks to prevent and/or treat influenza.

DOI 10.1164/rccm.201501-0188OC
Citations Scopus - 11
Co-authors Peter Wark, Alan Hsu, Malcolm Starkey, Paul Foster, Darryl Knight
2015 Sozo F, Horvat JC, Essilfie AT, O'Reilly M, Hansbro PM, Harding R, 'Altered lung function at mid-adulthood in mice following neonatal exposure to hyperoxia.', Respir Physiol Neurobiol, 218 21-27 (2015) [C1]
DOI 10.1016/j.resp.2015.07.004
Citations Scopus - 1
Co-authors Jay Horvat
2015 Grillo VL, Arzey KE, Hansbro PM, Hurt AC, Warner S, Bergfeld J, et al., 'Avian influenza in Australia: A summary of 5 years of wild bird surveillance', Australian Veterinary Journal, 93 387-393 (2015) [C1]

© 2015 Australian Veterinary Association.Background: Avian influenza viruses (AIVs) are found worldwide in numerous bird species, causing significant disease in gallinaceous poul... [more]

© 2015 Australian Veterinary Association.Background: Avian influenza viruses (AIVs) are found worldwide in numerous bird species, causing significant disease in gallinaceous poultry and occasionally other species. Surveillance of wild bird reservoirs provides an opportunity to add to the understanding of the epidemiology of AIVs. Methods: This study examined key findings from the National Avian Influenza Wild Bird Surveillance Program over a 5-year period (July 2007-June 2012), the main source of information on AIVs circulating in Australia. Results: The overall proportion of birds that tested positive for influenza A via PCR was 1.9±0.1%, with evidence of widespread exposure of Australian wild birds to most low pathogenic avian influenza (LPAI) subtypes (H1-13, H16). LPAI H5 subtypes were found to be dominant and widespread during this 5-year period. Conclusion: Given Australia's isolation, both geographically and ecologically, it is important for Australia not to assume that the epidemiology of AIV from other geographic regions applies here. Despite all previous highly pathogenic avian influenza outbreaks in Australian poultry being attributed to H7 subtypes, widespread detection of H5 subtypes in wild birds may represent an ongoing risk to the Australian poultry industry.

DOI 10.1111/avj.12379
Citations Scopus - 2
2015 Singanayagam A, Glanville N, Walton RP, Aniscenko J, Pearson RM, Pinkerton JW, et al., 'A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD.', Clin Sci (Lond), 129 245-258 (2015) [C1]
DOI 10.1042/CS20140654
Citations Scopus - 4
Co-authors Nathan Bartlett, Jay Horvat
2015 Plank MW, Maltby S, Tay HL, Stewart J, Eyers F, Hansbro PM, Foster PS, 'MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity.', PloS one, 10 1-25 (2015) [C1]
DOI 10.1371/journal.pone.0144810
Citations Scopus - 1
Co-authors Steven Maltby, Paul Foster
2015 Tolosa JM, Parsons KS, Hansbro PM, Smith R, Wark PB, 'The placental protein syncytin-1 impairs antiviral responses and exaggerates inflammatory responses to influenza', PLoS ONE, 10 (2015) [C1]

© 2015 Tolosa et al.Background Pregnancy increases susceptibility to influenza. The placenta releases an immunosuppressive endogenous retroviral protein syncytin-1.We hypothesise... [more]

© 2015 Tolosa et al.Background Pregnancy increases susceptibility to influenza. The placenta releases an immunosuppressive endogenous retroviral protein syncytin-1.We hypothesised that exposure of peripheral monocytes (PBMCs) to syncytin-1 would impair responses to H1N1pdm09 influenza. Methods and Findings Recombinant syncytin-1 was produced. PBMCs from non-pregnant women (n=10) were exposed to H1N1pdm09 in the presence and absence of syncytin-1 and compared to responses of PBMCs from pregnant women (n=12). PBMCs were characterised using flow cytometry, release of interferon (IFN)-a, IFN-¿, IFN-¿, IL-10, IL-2, IL-6 and IL-1ß were measured by cytometric bead array or ELISA. Exposure of PBMCs to H1N1pdm09 resulted in the release of IFN-a, (14,787 pg/mL, 95% CI 7311-22,264 pg/mL) IFN-¿ (1486 pg/mL, 95% CI 756-2216 pg/mL) and IFN-¿ (852 pg/mL, 95% CI 193-1511 pg/mL) after 48 hours. This was significantly impaired in pregnant women (IFN-a; p<0.0001 and IFN-¿; p<0.001). Furthermore, in the presence of syncytin-1, PBMCs demonstrated marked reductions in IFN-a and IFN-¿, while enhanced release of IL-10 as well as IL-6 and IL-1ß. Conclusions Our data indicates that a placental derived protein, syncytin-1 may be responsible for the heightened vulnerability of pregnant women to influenza.

DOI 10.1371/journal.pone.0118629
Citations Scopus - 5Web of Science - 2
Co-authors Roger Smith, Peter Wark
2015 Hirota JA, Gold MJ, Hiebert PR, Parkinson LG, Wee T, Smith D, et al., 'The Nucleotide-Binding Domain, Leucine-Rich Repeat Protein 3 Inflammasome/IL-1 Receptor I Axis Mediates Innate, but Not Adaptive, Immune Responses after Exposure to Particulate Matter under 10 mu m', AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 52 96-105 (2015) [C1]
DOI 10.1165/rcmb.2014-0158OC
Citations Scopus - 5Web of Science - 1
Co-authors Darryl Knight
2015 Ge Q, Chen L, Jaffar J, Argraves WS, Twal WO, Hansbro P, et al., 'Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts', SCIENTIFIC REPORTS, 5 (2015) [C1]
DOI 10.1038/srep09496
Citations Scopus - 1
2015 Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM, 'Inflammasomes in COPD and neutrophilic asthma', THORAX, 70 1199-1201 (2015) [C1]
DOI 10.1136/thoraxjnl-2014-206736
Citations Scopus - 1
Co-authors Jay Horvat, Peter Gibson
2015 Tay HL, Kaiko GE, Plank M, Li JJ, Maltby S, Essilfie AT, et al., 'Antagonism of miR-328 Increases the Antimicrobial Function of Macrophages and Neutrophils and Rapid Clearance of Non-typeable Haemophilus Influenzae (NTHi) from Infected Lung', PLoS Pathogens, 11 (2015) [C1]

© 2015 Tay et al.Pathogenic bacterial infections of the lung are life threatening and underpin chronic lung diseases. Current treatments are often ineffective potentially due to ... [more]

© 2015 Tay et al.Pathogenic bacterial infections of the lung are life threatening and underpin chronic lung diseases. Current treatments are often ineffective potentially due to increasing antibiotic resistance and impairment of innate immunity by disease processes and steroid therapy. Manipulation miRNA directly regulating anti-microbial machinery of the innate immune system may boost host defence responses. Here we demonstrate that miR-328 is a key element of the host response to pulmonary infection with non-typeable haemophilus influenzae and pharmacological inhibition in mouse and human macrophages augments phagocytosis, the production of reactive oxygen species, and microbicidal activity. Moreover, inhibition of miR-328 in respiratory models of infection, steroid-induced immunosuppression, and smoke-induced emphysema enhances bacterial clearance. Thus, miRNA pathways can be targeted in the lung to enhance host defence against a clinically relevant microbial infection and offer a potential new anti-microbial approach for the treatment of respiratory diseases.

DOI 10.1371/journal.ppat.1004549
Citations Scopus - 4
Co-authors Steven Maltby, Ming Yang, Joerg Mattes, Paul Foster
2015 Dhouib R, Pg Othman DSM, Essilfie AT, Hansbro PM, Hanson JO, McEwan AG, Kappler U, 'Maturation of molybdoenzymes and its influence on the pathogenesis of non-typeable Haemophilus influenzae', Frontiers in Microbiology, 6 (2015) [C1]

© 2015 Dhouib, Pg Othman, Essilfie, Hansbro, Hanson, McEwan and Kappler.Mononuclear molybdenum enzymes of the dimethylsulfoxide (DMSO) reductase family occur exclusively in proka... [more]

© 2015 Dhouib, Pg Othman, Essilfie, Hansbro, Hanson, McEwan and Kappler.Mononuclear molybdenum enzymes of the dimethylsulfoxide (DMSO) reductase family occur exclusively in prokaryotes, and a loss of some these enzymes has been linked to a loss of bacterial virulence in several cases. The MobA protein catalyzes the final step in the synthesis of the molybdenum guanine dinucleotide (MGD) cofactor that is exclusive to enzymes of the DMSO reductase family. MobA has been proposed as a potential target for control of virulence since its inhibition would affect the activities of all molybdoenzymes dependent upon MGD. Here, we have studied the phenotype of a mobA mutant of the host-adapted human pathogen Haemophilus influenzae. H. influenzae causes and contributes to a variety of acute and chronic diseases of the respiratory tract, and several enzymes of the DMSO reductase family are conserved and highly expressed in this bacterium. The mobA mutation caused a significant decrease in the activities of all Mo-enzymes present, and also resulted in a small defect in anaerobic growth. However, we did not detect a defect in in vitro biofilm formation nor in invasion and adherence to human epithelial cells in tissue culture compared to the wild-type. In a murine in vivo model, the mobA mutant showed only a mild attenuation compared to the wild-type. In summary, our data show that MobA is essential for the activities of molybdenum enzymes, but does not appear to affect the fitness of H. influenzae. These results suggest that MobA is unlikely to be a useful target for antimicrobials, at least for the purpose of treating H. influenzae infections.

DOI 10.3389/fmicb.2015.01219
2014 Starkey MR, Nguyen DH, Essilfie AT, Kim RY, Hatchwell LM, Collison AM, et al., 'Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.', Mucosal Immunol, 7 478-488 (2014) [C1]
DOI 10.1038/mi.2013.65
Citations Scopus - 4
Co-authors Paul Foster, Jay Horvat, Malcolm Starkey, Joerg Mattes
2014 Franklin BS, Bossaller L, De Nardo D, Ratter JM, Stutz A, Engels G, et al., 'The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation.', Nat Immunol, 15 727-737 (2014) [C1]
DOI 10.1038/ni.2913
Citations Scopus - 83Web of Science - 47
2014 Olson SH, Parmley J, Soos C, Gilbert M, Latorre-Margalef N, Hall JS, et al., 'Sampling strategies and biodiversity of influenza A subtypes in wild birds', PLoS ONE, 9 (2014) [C1]

Wild aquatic birds are recognized as the natural reservoir of avian influenza A viruses (AIV), but across high and low pathogenic AIV strains, scientists have yet to rigorously id... [more]

Wild aquatic birds are recognized as the natural reservoir of avian influenza A viruses (AIV), but across high and low pathogenic AIV strains, scientists have yet to rigorously identify most competent hosts for the various subtypes. We examined 11,870 GenBank records to provide a baseline inventory and insight into patterns of global AIV subtype diversity and richness. Further, we conducted an extensive literature review and communicated directly with scientists to accumulate data from 50 non-overlapping studies and over 250,000 birds to assess the status of historic sampling effort. We then built virus subtype sample-based accumulation curves to better estimate sample size targets that capture a specific percentage of virus subtype richness at seven sampling locations. Our study identifies a sampling methodology that will detect an estimated 75% of circulating virus subtypes from a targeted bird population and outlines future surveillance and research priorities that are needed to explore the influence of host and virus biodiversity on emergence and transmission.

DOI 10.1371/journal.pone.0090826
Citations Scopus - 12Web of Science - 8
2014 Grafton KT, Moir LM, Black JL, Hansbro NG, Hansbro PM, Burgess JK, Oliver BG, 'LF-15 & T7, synthetic peptides derived from tumstatin, attenuate aspects of airway remodelling in a murine model of chronic OVA-induced allergic airway disease', PLoS ONE, 9 (2014) [C1]

Background: Tumstatin is a segment of the collagen-IV protein that is markedly reduced in the airways of asthmatics. Tumstatin can play an important role in the development of air... [more]

Background: Tumstatin is a segment of the collagen-IV protein that is markedly reduced in the airways of asthmatics. Tumstatin can play an important role in the development of airway remodelling associated with asthma due to its antiangiogenic properties. This study assessed the anti-angiogenic properties of smaller peptides derived from tumstatin, which contain the interface tumstatin uses to interact with the aVb3 integrin. Methods: Primary human lung endothelial cells were exposed to the LF-15, T3 and T7 tumstatin-derived peptides and assessed for cell viability and tube formation in vitro. The impact of the anti-angiogenic properties on airways hyperresponsiveness (AHR) was then examined using a murine model of chronic OVA-induced allergic airways disease. Results: The LF-15 and T7 peptides significantly reduced endothelial cell viability and attenuated tube formation in vitro. Mice exposed to OVA+ LF-15 or OVA+T7 also had reduced total lung vascularity and AHR was attenuated compared to mice exposed to OVA alone. T3 peptides reduced cell viability but had no effect on any other parameters. Conclusion: The LF-15 and T7 peptides may be appropriate candidates for use as novel pharmacotherapies due to their small size and anti-angiogenic properties observed in vitro and in vivo. © 2014 Grafton et al.

DOI 10.1371/journal.pone.0085655
Citations Scopus - 2Web of Science - 2
Co-authors Nicole Hansbro
2014 Rehaume LM, Mondot S, Aguirre De Cárcer D, Velasco J, Benham H, Hasnain SZ, et al., 'ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice', Arthritis and Rheumatology, 66 2780-2792 (2014) [C1]

Copyright © 2014 by the American College of Rheumatology.Objective The spondyloarthritides share genetic susceptibility, interleukin-23 (IL-23) dependence, and the involvement of... [more]

Copyright © 2014 by the American College of Rheumatology.Objective The spondyloarthritides share genetic susceptibility, interleukin-23 (IL-23) dependence, and the involvement of microbiota. The aim of the current study was to elucidate how host genetics influence gut microbiota and the relationship between microbiota and organ inflammation in spondyloarthritides.Methods BALB/c ZAP-70W163C-mutant (SKG) mice, Toll-like receptor 4 (TLR-4)-deficient SKG mice, and wild-type BALB/c mice were housed under specific pathogen-free conditions. SKG and wild-type BALB/c mice were maintained under germ-free conditions, and some of these mice were recolonized with altered Schaedler flora. All of the mice were injected intraperitoneally with microbial ß-1,3-glucan (curdlan). Arthritis, spondylitis, and ileitis were assessed histologically. Microbiome composition was analyzed in serial fecal samples obtained from mice that were co-housed beginning at the time of weaning, using 454 pyrosequencing. Infiltrating cells and cytokines in the peritoneal cavity were measured by flow cytometry and enzyme-linked immunosorbent assay. Cytokine, endoplasmic reticulum (ER) stress marker, and tight junction protein transcription was measured by quantitative real-time polymerase chain reaction.Results Microbiota content and response to curdlan varied according to whether T cell receptor signal strength was normal or was impaired due to the ZAP-70W163C mutation. Curdlan triggered acute inflammation regardless of the presence of the SKG allele or microbiota. However, no or limited microbiota content attenuated the severity of arthritis. In contrast, ileal IL-23 expression, ER stress, lymph node IL-17A production, goblet cell loss, and ileitis development were microbiota-dependent. Ileitis but not arthritis was suppressed by microbiota transfer upon co-housing SKG mice with wild-type BALB/c mice, as well as by TLR-4 deficiency.Conclusion The interaction between immunogenetic background and host microbiota leads to an IL-23-dependent loss of mucosal function, triggering ileitis in response to curdlan.

DOI 10.1002/art.38773
Citations Scopus - 26Web of Science - 9
2014 Keely S, Hansbro PM, 'Lung-Gut Cross Talk A Potential Mechanism for Intestinal Dysfunction in Patients With COPD', CHEST, 145 199-200 (2014) [C3]
DOI 10.1378/chest.13-2077
Citations Scopus - 7Web of Science - 2
Co-authors Simon Keely
2014 Jaffer J, Unger S, Corte TJ, Keller M, Wolters PJ, Richeldi L, et al., 'Fibulin-1 Predicts Disease Progression in Patients With Idiopathic Pulmonary Fibrosis', CHEST, 146 1055-1063 (2014) [C1]
DOI 10.1378/chest.13-2688
Citations Web of Science - 3
2014 Hansbro PM, Hamilton MJ, Fricker M, Gellatly SL, Jarnicki AG, Zheng D, et al., 'Importance of mast cell Prss31/transmembrane tryptase/tryptase-¿ in lung function and experimental chronic obstructive pulmonary disease and colitis', Journal of Biological Chemistry, 289 18214-18227 (2014) [C1]

Protease serine member S31 (Prss31)/transmembrane tryptase/tryptase-¿ is a mast cell (MC)-restricted protease of unknown function that is retained on the outer leaflet of the pla... [more]

Protease serine member S31 (Prss31)/transmembrane tryptase/tryptase-¿ is a mast cell (MC)-restricted protease of unknown function that is retained on the outer leaflet of the plasma membrane when MCs are activated. We determined the nucleotide sequences of the Prss31 gene in different mouse strains and then used a Cre/loxP homologous recombination approach to create a novel Prss31 -/- C57BL/6 mouse line. The resulting animals exhibited no obvious developmental abnormality, contained normal numbers of granulated MCs in their tissues, and did not compensate for their loss of the membrane tryptase by increasing their expression of other granule proteases. When Prss31-null MCs were activated with a calcium ionophore or by their high affinity IgE receptors, they degranulated in a pattern similar to that of WT MCs. Prss31-null mice had increased baseline airway reactivity to methacholine but markedly reduced experimental chronic obstructive pulmonary disease and colitis, thereby indicating both beneficial and adverse functional roles for the tryptase. In a cigarette smokeinduced model of chronic obstructive pulmonary disease, WT mice had more pulmonary macrophages, higher histopathology scores, and more fibrosis in their small airways than similarly treated Prss31-null mice. In a dextran sodium sulfate-induced acute colitis model, WT mice lost more weight, had higher histopathology scores, and contained more Cxcl-2 and IL-6 mRNA in their colons than similarly treated Prss31-null mice. The accumulated data raise the possibility that inhibitors of this membrane tryptase may provide additional therapeutic benefit in the treatment of humans with these MC-dependent inflammatory diseases. © 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

DOI 10.1074/jbc.M114.548594
Citations Scopus - 14Web of Science - 3
Co-authors Paul Foster, Michael Fricker
2014 Chevalier N, Thorburn AN, Macia L, Tan J, Juglair L, Yagita H, et al., 'Inflammation and lymphopenia trigger autoimmunity by suppression of il-2-controlled regulatory t cell and increase of il-21-mediated effector t cell expansion', Journal of Immunology, 193 4845-4858 (2014) [C1]

© 2014 by The American Association of Immunologists, Inc.The dynamic interplay between regulatory T cells (Tregs) and effector T cells (Teffs) governs the balance between toleran... [more]

© 2014 by The American Association of Immunologists, Inc.The dynamic interplay between regulatory T cells (Tregs) and effector T cells (Teffs) governs the balance between tolerance and effector immune responses. Perturbations of Treg frequency and function or imbalances in Treg/Teff levels are associated with the development of autoimmunity. The factors that mediate these changes remain poorly understood and were investigated in this study in murine autoimmune arthritis. Tregs displayed a stable phenotype in arthritic mice and were fully functional in in vitro suppression assays. However, their expansion was delayed relative to Teffs (T follicular helper cells and Th17 cells) during the early stages of autoimmune reactivity. This imbalance is likely to have led to insufficient Treg control of Teffs and induced autoimmunity. Moreover, a counterregulatory and probably IL-7-driven increase in thymic Treg production and recruitment to inflamed tissues was too slow for disease prevention. Increased Teff over Treg expansion was further aggravated by inflammation and lymphopenia. Both these conditions contribute to autoimmune pathogenesis and were accompanied by decreases in the availability of IL-2 and increases in levels of IL-21. IL-2 neutralization or supplementation was used to show that Treg expansion mainly depended on this cytokine. IL-21R2/2 cells were used to demonstrate that IL-21 promoted the maintenance of Teffs. Thus, at inflammatory sites in experimental arthritis, a deficit in IL-2 hampers Treg proliferation, whereas exaggerated IL-21 levels overwhelm Treg control by supporting Teff expansion. This identifies IL-2 and IL-21 as targets for manipulation in therapies for autoimmunity.

DOI 10.4049/jimmunol.1302966
Citations Scopus - 2
2014 McIlroy DJ, Jarnicki AG, Au GG, Lott N, Smith DW, Hansbro PM, Balogh ZJ, 'Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery', Journal of Critical Care, 29 1133.e1-1133.e5 (2014) [C1]

© 2014 The Authors.Introduction: Neutrophil extracellular traps (NETs) have not been demonstrated after trauma and subsequent surgery. Neutrophil extracellular traps are formed f... [more]

© 2014 The Authors.Introduction: Neutrophil extracellular traps (NETs) have not been demonstrated after trauma and subsequent surgery. Neutrophil extracellular traps are formed from pure mitochondrial DNA (mtDNA) under certain conditions, which is potently proinflammatory. We hypothesized that injury and orthopedic trauma surgery would induce NET production with mtDNA as a structural component. Methods: Neutrophils were isolated 8 trauma patients requiring orthopedic surgery postinjury and up to 5 days postoperatively. Four healthy volunteers provided positive and negative controls. Total hip replacement patients acted as an uninjured surgical control group. Neutrophil extracellular traps were visualized with DNA (Hoechst 33342TM/Sytox Green/MitoSox/MitoTracker) stains using live cell fluorescence microscopy with downstream quantitative polymerase chain reaction analysis of DNA composition. Results: Neutrophil extracellular traps were present after injury in all 8 trauma patients. They persisted for 5 days postoperatively. Delayed surgery resulted in NET resolution, but they reformed postoperatively. Total hip replacement patients developed NETs postoperatively, which resolved by day 5. Quantitative polymerase chain reaction analysis of NET-DNA composition revealed that NETs formed after injury and surgery were made of mtDNA with no detectable nuclear DNA component. Conclusions: Neutrophil extracellular traps formed after major trauma and subsequent surgery contain mtDNA and represent a novel marker of heightened innate immune activation. They could be considered when timing surgery after trauma to prevent systemic NET-induced inflammatory complications.

DOI 10.1016/j.jcrc.2014.07.013
Citations Scopus - 6
Co-authors Gough Au, Douglas Smith, Zsolt Balogh
2014 Prieto-García A, Castells MC, Hansbro PM, Stevens RL, 'Mast cell-restricted tetramer-forming tryptases and their beneficial roles in hemostasis and blood coagulation', Immunology and Allergy Clinics of North America, 34 263-281 (2014) [C1]

Tetramer-forming tryptase (hTryptase-ß) was recently discovered to have a prominent role in preventing the internal accumulation of life-threatening fibrin deposits and fibrin-pl... [more]

Tetramer-forming tryptase (hTryptase-ß) was recently discovered to have a prominent role in preventing the internal accumulation of life-threatening fibrin deposits and fibrin-platelet clots. The anticoagulant activity of hTryptase-ß is an explanation for the presence of hemorrhagic disorders in some patients with anaphylaxis or mastocytosis. The fragments of hFibrinogen formed by the proteolysis of this prominent protein by hTryptase-ß could be used as biomarkers in the blood and/or urine for the identification and monitoring of patients with mast cell-dependent disorders. Recombinant hTryptase-ß has potential to be used in clinical settings where it is desirable to inhibit blood coagulation. © 2014 Elsevier Inc.

DOI 10.1016/j.iac.2014.01.001
Citations Scopus - 2Web of Science - 2
2014 Hallstrand TS, Hackett TL, Altemeier WA, Matute-Bello G, Hansbro PM, Knight DA, 'Airway epithelial regulation of pulmonary immune homeostasis and inflammation', Clinical Immunology, 151 1-15 (2014) [C1]

Recent genetic, structural and functional studies have identified the airway and lung epithelium as a key orchestrator of the immune response. Further, there is now strong evidenc... [more]

Recent genetic, structural and functional studies have identified the airway and lung epithelium as a key orchestrator of the immune response. Further, there is now strong evidence that epithelium dysfunction is involved in the development of inflammatory disorders of the lung. Here we review the characteristic immune responses that are orchestrated by the epithelium in response to diverse triggers such as pollutants, cigarette smoke, bacterial peptides, and viruses. We focus in part on the role of epithelium-derived interleukin (IL)-25, IL-33 and thymic stromal lymphopoietin (TSLP), as well as CC family chemokines as critical regulators of the immune response. We cite examples of the function of the epithelium in host defense and the role of epithelium dysfunction in the development of inflammatory diseases. © 2013 Elsevier Inc.

DOI 10.1016/j.clim.2013.12.003
Citations Scopus - 39Web of Science - 19
Co-authors Darryl Knight
2014 Hirota JA, Alexis NE, Pui M, Wong S, Fung E, Hansbro P, et al., 'PM10-stimulated airway epithelial cells activate primary human dendritic cells independent of uric acid: Application of an in vitro model system exposing dendritic cells to airway epithelial cell-conditioned media', Respirology, 19 881-890 (2014) [C1]

Background and objective Airway epithelial cells represent the first line of defence against inhaled insults, including air pollution. Air pollution can activate innate immune sig... [more]

Background and objective Airway epithelial cells represent the first line of defence against inhaled insults, including air pollution. Air pollution can activate innate immune signalling in airway epithelial cells leading to the production of soluble mediators that can influence downstream inflammatory cells. Our objective was to develop and validate a model of dendritic cell exposure to airway epithelial cell-conditioned media. After establishing the model, we explored how soluble mediators released from airway epithelial cells in response to air pollution influenced the phenotype of dendritic cells. Methods Human airway epithelial cells were cultured under control and urban particulate matter (PM10) exposure conditions with or without pharmacological inhibitors of the uric acid pathway. Culture supernatants were collected for conditioned media experiments with peripheral blood mononuclear cell-derived dendritic cells analysed by flow cytometry. Results Monocytes derived from peripheral blood mononuclear cells cultured in interleukin-4 and granulocyte macrophage colony stimulating factor differentiated into immature dendritic cells that phenotypically differentiated into mature dendritic cells in response to conditioned media from phorbol myristate acetate-activated THP-1 monocytes. Exposure of immature dendritic cells to conditioned media from airway epithelial cells exposed to PM10 resulted in dendritic cell maturation that was independent of uric acid. Conclusions We present a conditioned media model useful for interrogating the contribution of soluble mediators produced by airway epithelial cells to dendritic cell phenotype and function. Furthermore, we demonstrate that PM10 exposure induces airway epithelial cell production of soluble mediators that induce maturation of dendritic cells independent of uric acid. We developed and validated a model of airway epithelial cell conditioned media exposure to primary human dendritic cells. Using this model, we then tested the hypothesis that urban particulate matter exposure to airway epithelial cells resulted in production of soluble mediators capable of inducing dendritic cell maturation. © 2014 Asian Pacific Society of Respirology.

DOI 10.1111/resp.12316
Citations Scopus - 4Web of Science - 1
Co-authors Darryl Knight
2014 Fricker M, Deane A, Hansbro PM, 'Animal models of chronic obstructive pulmonary disease', Expert Opinion on Drug Discovery, 9 629-645 (2014) [C1]

Introduction: Chronic obstructive pulmonary disease (COPD) is a leading global cause of mortality and chronic morbidity. Inhalation of cigarette smoke is the principal risk factor... [more]

Introduction: Chronic obstructive pulmonary disease (COPD) is a leading global cause of mortality and chronic morbidity. Inhalation of cigarette smoke is the principal risk factor for development of this disease. COPD is a progressive disease that is typically characterised by chronic pulmonary inflammation, mucus hypersecretion, airway remodelling and emphysema that collectively reduce lung function. There are currently no therapies that effectively halt or reverse disease progression. It is hoped that the development of animal models that develop the hallmark features of COPD, in a short time frame, will aid in the identifying and testing of new therapeutic approaches. Areas covered: The authors review the recent developments in mouse models of chronic cigarette smoke-induced COPD as well as the principal findings. Furthermore, the authors discuss the use of mouse models to understand the pathogenesis and the contribution of infectious exacerbations. They also discuss the investigations of the systemic co-morbidities of COPD (pulmonary hypertension, cachexia and osteoporosis). Expert opinion: Recent advances in the field mark a point where animal models recapitulate the pathologies of COPD patients in a short time frame. They also reveal novel insights into the pathogenesis and potential treatment of this debilitating disease. © 2014 Informa UK, Ltd.

DOI 10.1517/17460441.2014.909805
Citations Scopus - 19Web of Science - 10
Co-authors Michael Fricker
2014 Simpson JL, Powell H, Baines KJ, Milne D, Coxson HO, Hansbro PM, Gibson PG, 'The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial', PLOS ONE, 9 (2014) [C1]
DOI 10.1371/journal.pone.0105609
Citations Scopus - 5Web of Science - 3
Co-authors Jodie Simpson, Peter Gibson, Katherine Baines
2014 O'Reilly M, Hansbro PM, Horvat JC, Beckett EL, Harding R, Sozo F, 'Bronchiolar Remodeling in Adult Mice Following Neonatal Exposure to Hyperoxia: Relation to Growth', Anatomical Record, 297 758-769 (2014) [C1]

Preterm infants who receive supplemental oxygen for prolonged periods are at increased risk of impaired lung function later in life. This suggests that neonatal hyperoxia induces ... [more]

Preterm infants who receive supplemental oxygen for prolonged periods are at increased risk of impaired lung function later in life. This suggests that neonatal hyperoxia induces persistent changes in small conducting airways (bronchioles). Although the effects of neonatal hyperoxia on alveolarization are well documented, little is known about its effects on developing bronchioles. We hypothesized that neonatal hyperoxia would remodel the bronchiolar walls, contributing to altered lung function in adulthood. We studied three groups of mice (C57BL/6J) to postnatal day 56 (P56; adulthood) when they either underwent lung function testing or necropsy for histological analysis of the bronchiolar wall. One group inhaled 65% O2 from birth until P7, after which they breathed room air; this group experienced growth restriction (HE+GR group). We also used a group in which hyperoxia-induced GR was prevented by dam rotation (HE group). A control group inhaled room air from birth. At P56, the bronchiolar epithelium of HE mice contained fewer Clara cells and more ciliated cells, and the bronchiolar wall contained ~25% less collagen than controls; in HE+GR mice the bronchiolar walls had ~13% more collagen than controls. Male HE and HE+GR mice had significantly thicker bronchiolar epithelium than control males and altered lung function (HE males: greater dynamic compliance; HE+GR males: lower dynamic compliance). We conclude that neonatal hyperoxia remodels the bronchiolar wall and, in adult males, affects lung function, but effects are altered by concomitant growth restriction. Our findings may partly explain the reports of poor lung function in ex-preterm children and adults. Anat Rec, 297:758-769, 2014. © 2014 Wiley Periodicals, Inc.

DOI 10.1002/ar.22867
Citations Scopus - 6Web of Science - 2
Co-authors Jay Horvat
2014 Keely S, Campbell EL, Baird AW, Hansbro PM, Shalwitz RA, Kotsakis A, et al., 'Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis', Mucosal Immunology, 7 114-123 (2014) [C1]

Pharmacological stabilization of hypoxia-inducible factor (HIF) through prolyl hydroxylase (PHD) inhibition limits mucosal damage associated with models of murine colitis. However... [more]

Pharmacological stabilization of hypoxia-inducible factor (HIF) through prolyl hydroxylase (PHD) inhibition limits mucosal damage associated with models of murine colitis. However, little is known about how PHD inhibitors (PHDi) influence systemic immune function during mucosal inflammation or the relative importance of immunological changes to mucosal protection. We hypothesized that PHDi enhances systemic innate immune responses to colitis-associated bacteremia. Mice with colitis induced by trinitrobenzene sulfonic acid were treated with AKB-4924, a new HIF-1 isoform-predominant PHDi, and clinical, immunological, and biochemical endpoints were assessed. Administration of AKB-4924 led to significantly reduced weight loss and disease activity compared with vehicle controls. Treated groups were pyrexic but did not become subsequently hypothermic. PHDi treatment augmented epithelial barrier function and led to an approximately 50-fold reduction in serum endotoxin during colitis. AKB-4924 also decreased cytokines involved in pyrogenesis and hypothermia, significantly reducing serum levels of interleukin (IL)-1ß, IL-6, and tumor necrosis factor (TNF)-a while increasing IL-10. Treatment offered no protection against colitis in epithelial-specific HIF-1a-deficient mice, strongly implicating epithelial HIF-1a as the tissue target for AKB-4924-mediated protection. Taken together, these results indicate that inhibition of prolyl hydroxylase with AKB-4924 enhances innate immunity and identifies that the epithelium is a central site of inflammatory protection afforded by PHDi in murine colitis. © 2014 Society for Mucosal Immunology.

DOI 10.1038/mi.2013.29
Citations Scopus - 25Web of Science - 13
Co-authors Simon Keely
2014 Chambers DC, Gellatly SL, Hugenholtz P, Hansbro PM, 'JTD special edition 'Hot Topics in COPD'-The microbiome in COPD', Journal of Thoracic Disease, 6 1525-1531 (2014) [C1]

© 2014 American Thoracic Society.The pathogenesis of chronic obstructive pulmonary disease (COPD) and its exacerbations, are intricately linked to colonisation and infection with... [more]

© 2014 American Thoracic Society.The pathogenesis of chronic obstructive pulmonary disease (COPD) and its exacerbations, are intricately linked to colonisation and infection with bacteria and other microbes. Despite their undeniable importance, we have a poor understanding of the complex relationships between COPD phenotypes, physiology, cellular and molecular biology and the roles of colonising microbe or infecting pathogens. The management algorithms for the care of patients with COPD that include microbial influences, have almost exclusively been developed using microbial methods that were entirely dependent on the ability to grow bacteria on suitable media. The shortcomings of this approach are becoming clear now that it is possible to completely and accurately define the microbial ecology of ecosystems using genomic methods, which do not rely on the ability to cultivate the organisms present. Whilst our appreciation of the relationships between some bacterial ecosystems and the organ in which they reside in humans is now relatively advanced, this is not true for lung. This perspective serves to highlight the growing importance of including an accurate description of bacterial ecology in any attempt to decipher the pathobiology of COPD. While this field is in its infancy, there is significant potential to gain new insights which will translate into more rational and effective treatment algorithms for patients with COPD.

DOI 10.3978/j.issn.2072-1439.2014.11.08
Citations Scopus - 5Web of Science - 4
2014 Hansbro PM, Starkey MR, Mattes J, Horvat JC, 'Pulmonary immunity during respiratory infections in early life and the development of severe asthma', Annals of the American Thoracic Society, 11 S297-S302 (2014) [C1]

Copyright © 2014 by the American Thoracic SocietyAsthma affects 10% of the population in Westernized countries, being most common in children. It is a heterogeneous condition cha... [more]

Copyright © 2014 by the American Thoracic SocietyAsthma affects 10% of the population in Westernized countries, being most common in children. It is a heterogeneous condition characterized by chronic allergic airway inflammation, mucus hypersecretion, and airway hyperresponsiveness (AHR) to normally innocuous antigens. Combination therapies with inhaled corticosteroids and bronchodilators effectively manage mild to moderate asthma, but there are no cures, and patients with severe asthma do not respond to these treatments. The inception of asthma is linked to respiratory viral (respiratory syncytial virus, rhinovirus) and bacterial (Chlamydia, Mycoplasma) infections. The examination of mouse models of early-life infections and allergic airway disease (AAD) provides valuable insights into the mechanisms of disease inception that may lead to the development of more effective therapeutics. For example, early-life, but not adult, Chlamydia respiratory infections in mice permanently modify immunity and lung physiology. This increases the severity of AAD by promoting IL-13 expression, mucus hypersecretion, and AHR. We have identified novel roles for tumor necrosis factor-related apoptosisinducing ligand (TRAIL) and IL-13 in promoting infection-induced pathology in early life and subsequent chronic lung disease. Genetic deletion of TRAIL or IL-13 variously protected against neonatal infection-induced inflammation, mucus hypersecretion, altered lung structure, AHR, and impaired lung function. Therapeutic neutralization of these factors prevented infection-induced severe AAD. Other novel mechanisms and avenues for intervention are also being explored. Such studies indicate the immunological mechanisms that may underpin the association between early-life respiratory infections and the development of more severe asthma and may facilitate the development of tailored preventions and treatments.

DOI 10.1513/AnnalsATS.201402-086AW
Citations Scopus - 2
Co-authors Jay Horvat, Malcolm Starkey, Joerg Mattes
2014 Sobinoff AP, Sutherland JM, Beckett EL, Stanger SJ, Johnson R, Jarnicki AG, et al., 'Damaging legacy: maternal cigarette smoking has long-term consequences for male offspring fertility.', Hum Reprod, 29 2719-2735 (2014) [C1]
DOI 10.1093/humrep/deu235
Citations Scopus - 12Web of Science - 3
Co-authors Eileen Mclaughlin, Adam Mccluskey, Jessie Sutherland
2013 Starkey MR, Nguyen DH, Kim RY, Nair PM, Brown AC, Essifie A-T, et al., 'Programming of the Lung in Early Life by Bacterial Infections Predisposes to Chronic Respiratory Disease', CLINICAL OBSTETRICS AND GYNECOLOGY, 56 566-576 (2013) [C1]
DOI 10.1097/GRF.0b013e3182993a0c
Citations Scopus - 4Web of Science - 2
Co-authors Malcolm Starkey, Jay Horvat
2013 Hansbro P, Beckett E, Stevens R, Jarnicki A, Wark P, Foster P, 'A short-term model of COPD identifies a role for mast cell tryptase', EUROPEAN RESPIRATORY JOURNAL, 42 (2013)
Co-authors Jay Horvat, Simon Keely, Paul Foster, Peter Wark
2013 Thorburn AN, Brown AC, Nair PM, Chevalier N, Foster PS, Gibson PG, Hansbro PM, 'Pneumococcal Components Induce Regulatory T Cells That Attenuate the Development of Allergic Airways Disease by Deviating and Suppressing the Immune Response to Allergen', JOURNAL OF IMMUNOLOGY, 191 4112-4120 (2013) [C1]
DOI 10.4049/jimmunol.1201232
Citations Scopus - 6Web of Science - 4
Co-authors Paul Foster, Peter Gibson
2013 Vijaykrishna D, Deng Y-M, Su YCF, Fourment M, Iannello P, Arzey GG, et al., 'The Recent Establishment of North American H10 Lineage Influenza Viruses in Australian Wild Waterfowl and the Evolution of Australian Avian Influenza Viruses', JOURNAL OF VIROLOGY, 87 10182-10189 (2013) [C1]
DOI 10.1128/JVI.03437-12
Citations Scopus - 13Web of Science - 10
2013 Fung KY, Mangan NE, Cumming H, Horvat JC, Mayall JR, Stifter SA, et al., 'Interferon-epsilon Protects the Female Reproductive Tract from Viral and Bacterial Infection', SCIENCE, 339 1088-1092 (2013) [C1]
DOI 10.1126/science.1233321
Citations Scopus - 39Web of Science - 36
Co-authors Jay Horvat
2013 Sobinoff AP, Beckett EL, Jarnicki AG, Sutherland JM, McCluskey A, Hansbro PM, McLaughlin EA, 'Scrambled and fried: Cigarette smoke exposure causes antral follicle destruction and oocyte dysfunction through oxidative stress', TOXICOLOGY AND APPLIED PHARMACOLOGY, 271 156-167 (2013) [C1]
DOI 10.1016/j.taap.2013.05.009
Citations Scopus - 13Web of Science - 11
Co-authors Adam Mccluskey, Jessie Sutherland, Eileen Mclaughlin
2013 Beckett EL, Stevens RL, Jarnicki AG, Kim RY, Hanish I, Hansbro NG, et al., 'A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis', The Journal of Allergy and Clinical Immunology, 131 752-762 (2013) [C1]
Citations Scopus - 50Web of Science - 34
Co-authors Nicole Hansbro, Simon Keely, Paul Foster, Jay Horvat, Peter Wark, Ming Yang
2013 Foster PS, Plank MW, Collison AM, Tay HL, Kaiko GE, Li J, et al., 'The emerging role of microRNAs in regulating immune and inflammatory responses in the lung', Immunological Reviews, 253 198-215 (2013) [C1]
Citations Scopus - 20Web of Science - 16
Co-authors Ming Yang, Joerg Mattes, Paul Foster
2013 Balogh ZJ, McIlroy DJ, Smith DW, Hansbro PM, 'The origin and the role of mitochondrial DNA in postinjury inflammation', Journal of Critical Care, 28 1099-1100 (2013) [C3]
DOI 10.1016/j.jcrc.2013.08.027
Citations Scopus - 3Web of Science - 2
Co-authors Zsolt Balogh, Douglas Smith
2013 Griekspoor P, Colles FM, Mccarthy ND, Hansbro PM, Ashhurst-Smith C, Olsen B, et al., 'Marked host specificity and lack of phylogeographic population structure of Campylobacter jejuni in wild birds', MOLECULAR ECOLOGY, 22 1463-1472 (2013) [C1]
DOI 10.1111/mec.12144
Citations Scopus - 25Web of Science - 16
2013 Simpson JL, McDonald VM, Baines KJ, Oreo KM, Wang F, Hansbro PM, Gibson PG, 'Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD', MEDIATORS OF INFLAMMATION, (2013) [C1]
DOI 10.1155/2013/462934
Citations Scopus - 10Web of Science - 7
Co-authors Jodie Simpson, Katherine Baines, Vanessa Mcdonald, Peter Gibson
2013 Hansbro PM, Knight DA, 'Are Lymphoid Follicles Important in the Pathogenesis of Chronic Obstructive Pulmonary Disease?', AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 188 267-269 (2013) [C3]
DOI 10.1164/rccm.201306-1073ED
Citations Scopus - 1Web of Science - 1
Co-authors Darryl Knight
2013 Hansbro PM, Scott GV, Essilfie A-T, Kim RY, Starkey MR, Nguyen D, et al., 'Th2 cytokine antagonists: Potential treatments for severe asthma', Expert Opinion on Investigational Drugs, 22 49-69 (2013) [C1]
Citations Scopus - 21Web of Science - 14
Co-authors Jay Horvat, Paul Foster, Malcolm Starkey, Ming Yang
2013 Starkey MR, Jarnicki AG, Essilfie A-T, Gellatly SL, Kim RY, Brown AC, et al., 'Murine models of infectious exacerbations of airway inflammation', CURRENT OPINION IN PHARMACOLOGY, 13 337-344 (2013) [C1]
DOI 10.1016/j.coph.2013.03.005
Citations Scopus - 14Web of Science - 8
Co-authors Jay Horvat, Paul Foster, Malcolm Starkey
2013 Li JJ, Tay HL, Plank M, Essilfie A-T, Hansbro PM, Foster PS, Yang M, 'Activation of Olfactory Receptors on Mouse Pulmonary Macrophages Promotes Monocyte Chemotactic Protein-1 Production', PLOS ONE, 8 (2013) [C1]
DOI 10.1371/journal.pone.0080148
Citations Scopus - 2Web of Science - 1
Co-authors Ming Yang, Paul Foster
2013 Starkey MR, Essilfie A-T, Horvat JC, Kim RY, Nguyen DH, Beagley KW, et al., 'Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease', Mucosal Immunology, 6 569-579 (2013) [C1]
Citations Scopus - 12Web of Science - 4
Co-authors Malcolm Starkey, Paul Foster, Jay Horvat, Joerg Mattes
2012 Wynne OL, Horvat JC, Smith R, Hansbro PM, Clifton VL, Hodgson DM, 'Effect of neonatal respiratory infection on adult BALB/c hippocampal glucocorticoid and mineralocorticoid receptors', Developmental Psychobiology, 54 568-575 (2012) [C1]
Citations Scopus - 2Web of Science - 1
Co-authors Jay Horvat, Olivia Wynne, Vicki Clifton, Deborah Hodgson, Roger Smith
2012 Prieto-Garcia A, Zheng D, Adachi R, Xing W, Xing W, Chung K, et al., 'Mast cell restricted mouse and human tryptase-heparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogen', Journal of Biological Chemistry, 287 7834-7844 (2012) [C1]
Citations Scopus - 20Web of Science - 16
2012 Thorburn AN, Foster PS, Gibson PG, Hansbro PM, 'Components of streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells', The Journal of Immunology, 188 4611-4620 (2012) [C1]
Citations Scopus - 29Web of Science - 20
Co-authors Paul Foster, Peter Gibson
2012 Essilfie A-T, Simpson JL, Dunkley ML, Morgan LC, Oliver BG, Gibson PG, et al., 'Combined haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma', Thorax, 67 588-599 (2012) [C1]
Citations Scopus - 43Web of Science - 32
Co-authors Paul Foster, Peter Gibson, Margaret Dunkley, Jodie Simpson
2012 Suthers B, Hansbro PM, Thambar S, McEvoy MA, Peel R, Attia JR, 'Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease', Vaccine, 30 3983-3985 (2012) [C1]
Citations Scopus - 6Web of Science - 5
Co-authors Mark Mcevoy, John Attia, Roseanne Peel
2012 Yang M, Kumar RK, Hansbro PM, Foster PS, 'Emerging roles of pulmonary macrophages in driving the development of severe asthma', Journal of Leukocyte Biology, 91 557-569 (2012) [C1]
Citations Scopus - 36Web of Science - 21
Co-authors Paul Foster, Ming Yang
2012 Hansbro PM, Jarnicki AG, 'Macrolides for macrophages in chronic obstructive pulmonary disease', Respirology, 17 739-740 (2012) [C3]
Citations Scopus - 5Web of Science - 4
2012 Hsu A, See HV, Hansbro PM, Wark PA, 'Innate immunity to influenza in chronic airways diseases', Respirology, 17 1166-1175 (2012) [C1]
Citations Scopus - 12Web of Science - 10
Co-authors Peter Wark, Alan Hsu
2012 Beckett EL, Phipps S, Starkey MR, Horvat JC, Beagley KW, Foster PS, Hansbro PM, 'TLR2, but not TLR4, is required for effective host defence against chlamydia respiratory tract infection in early life', PLOS One, 7 e39460 (2012) [C1]
Citations Scopus - 25Web of Science - 16
Co-authors Jay Horvat, Malcolm Starkey, Paul Foster
2012 Hsu A, Parsons KS, Barr I, Lowther S, Middleton D, Hansbro PM, Wark PA, 'Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection', PLoS One, 7 e32947 (2012) [C1]
DOI 10.1371/journal.pone.0032947
Citations Scopus - 22Web of Science - 21
Co-authors Peter Wark, Alan Hsu
2012 Starkey MR, Kim RY, Beckett EL, Schilter HC, Shim D, Essilfie A-T, et al., 'Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice', PLoS One, 7 e42588 (2012) [C1]
Citations Scopus - 9Web of Science - 6
Co-authors Jay Horvat, Joerg Mattes, Malcolm Starkey
2012 Keely S, Talley NJ, Hansbro PM, 'Pulmonary-intestinal cross-talk in mucosal inflammatory disease', Mucosal Immunology, 5 7-18 (2012) [C1]
Citations Scopus - 47Web of Science - 31
Co-authors Simon Keely, Nicholas Talley
2012 Hansbro PM, Starkey MR, Kim RY, Stevens RL, Foster PS, Horvat JC, 'Programming of the lung by early-life infection', Journal of Developmental Origins of Health and Disease, 3 153-158 (2012) [C1]
Citations Scopus - 7Web of Science - 4
Co-authors Paul Foster, Jay Horvat, Malcolm Starkey
2011 Essilfie A-T, Simpson JL, Horvat JC, Preston JA, Dunkley ML, Foster PS, et al., 'Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease', PLoS Pathogens, 7 e1002244 (2011) [C1]
Co-authors Peter Gibson, Paul Foster, Jay Horvat, Margaret Dunkley, Jodie Simpson
2011 Asquith KL, Horvat JC, Kaiko GE, Carey AJ, Beagley KW, Hansbro PM, Foster PS, 'Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts', PLoS Pathogens, 7 e1001339 (2011) [C1]
Citations Scopus - 30Web of Science - 20
Co-authors Jay Horvat, Paul Foster
2011 Temple SEL, Hansbro PM, 'New insights into the immune response to pneumococci', Current Respiratory Medicine Reviews, 7 257-261 (2011) [C1]
DOI 10.2174/157339811798281188
2011 Wang W, Hansbro PM, Foster PS, Yang M, 'An alternate STAT6-independent pathway promotes eosinophil influx into blood during allergic airway inflammation', PLoS ONE, 6 e17766 (2011) [C1]
DOI 10.1371/journal.pone.0017766
Citations Scopus - 7Web of Science - 6
Co-authors Ming Yang, Paul Foster
2011 Hansbro PM, Kaiko GE, Foster PS, 'Cytokine/anti-cytokine therapy - Novel treatments for asthma?', British Journal of Pharmacology, 163 81-95 (2011) [C2]
DOI 10.1111/j.1476-5381.2011.01219.x
Citations Scopus - 62Web of Science - 45
Co-authors Paul Foster
2011 Jennings PC, Merriman-Jones JA, Beckett EL, Hansbro PM, Jones KT, 'Increased zona pellucida thickness and meiotic spindle disruption in oocytes from cigarette smoking mice', Human Reproduction, 26 878-884 (2011) [C1]
DOI 10.1093/humrep/deq393
Citations Scopus - 18Web of Science - 13
Co-authors Keith Jones
2011 Wynne OL, Horvat JC, Kim RY, Ong LK, Smith R, Hansbro PM, et al., 'Neonatal respiratory infection and adult re-infection: Effect on glucocorticoid and mineralocorticoid receptors in the hippocampus in BALB/c mice', Brain Behavior and Immunity, 25 1214-1222 (2011) [C1]
DOI 10.1016/j.bbi.2011.03.014
Citations Scopus - 3Web of Science - 3
Co-authors Deborah Hodgson, Vicki Clifton, Roger Smith, Olivia Wynne, Linkooi Ong, Jay Horvat
2011 Preston JA, Thorburn AN, Starkey MR, Beckett EL, Horvat JC, Wade MA, et al., 'Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells', European Respiratory Journal, 37 53-64 (2011) [C1]
DOI 10.1183/09031936.00049510
Citations Scopus - 36Web of Science - 29
Co-authors Paul Foster, Peter Gibson, Malcolm Starkey, Jay Horvat
2011 Hazlewood LC, Wood LG, Hansbro PM, Foster PS, 'Dietary lycopene supplementation suppresses Th2 responses and lung eosinophilia in a mouse model of allergic asthma', Journal of Nutritional Biochemistry, 22 95-100 (2011) [C1]
DOI 10.1016/j.jnutbio.2009.12.003
Citations Scopus - 19Web of Science - 15
Co-authors Paul Foster, Lisa Wood
2011 Wynne OL, Horvat JC, Osei-Kumah A, Smith R, Hansbro PM, Clifton VL, Hodgson DM, 'Early life infection alters adult BALB/c hippocampal gene expression in a sex specific manner', Stress-the International Journal on the Biology of Stress, 14 247-261 (2011) [C1]
DOI 10.3109/10253890.2010.532576
Citations Scopus - 9Web of Science - 9
Co-authors Jay Horvat, Roger Smith, Olivia Wynne, Vicki Clifton, Deborah Hodgson
2011 Hsu A, Barr I, Hansbro PM, Wark PA, 'Human influenza is more effective than Avian influenza at antiviral suppression in airway cells', American Journal of Respiratory Cell and Molecular Biology, 44 906-913 (2011) [C1]
DOI 10.1165/rcmb.2010-0157OC
Citations Scopus - 14Web of Science - 10
Co-authors Peter Wark, Alan Hsu
2011 Hansbro PM, Hurt AC, 'Influenza surveillance in wild birds in Australia', Microbiology Australia, 32 48-51 (2011) [C1]
2010 Lau JY, Oliver BG, Baraket M, Beckett EL, Hansbro NG, Moir LM, et al., 'Fibulin-1 Is increased in asthma - A novel mediator of airway remodeling?', Plos One, 5 1-13 (2010) [C1]
DOI 10.1371/journal.pone.0013360
Citations Scopus - 19Web of Science - 15
Co-authors Nicole Hansbro, Paul Foster
2010 Horvat JC, Starkey MR, Kim RY, Beagley KW, Preston JA, Gibson PG, et al., 'Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease', Journal of Immunology, 184 4159-4169 (2010) [C1]
DOI 10.4049/jimmunol.0902287
Citations Scopus - 44Web of Science - 36
Co-authors Jay Horvat, Paul Foster, Peter Gibson, Malcolm Starkey
2010 Li J, Wang W, Baines KJ, Bowden NA, Hansbro PM, Gibson PG, et al., 'IL-27/IFN-y induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages', Journal of Immunology, 185 4401-4409 (2010) [C1]
DOI 10.4049/jimmunol.1001039
Citations Scopus - 46Web of Science - 34
Co-authors Peter Gibson, Ming Yang, Katherine Baines, Paul Foster, Nikola Bowden
2010 Thorburn AN, O'Sullivan BJ, Thomas R, Kumar RK, Foster PS, Gibson PG, Hansbro PM, 'Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease', Thorax, 65 1053-1060 (2010) [C1]
DOI 10.1136/thx.2009.131508
Citations Scopus - 32Web of Science - 29
Co-authors Paul Foster, Peter Gibson
2010 Horvat JC, Starkey MR, Kim RY, Phipps S, Gibson PG, Beagley KW, et al., 'Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology', Journal of Allergy and Clinical Immunology, 125 617-625 (2010) [C1]
DOI 10.1016/j.jaci.2009.10.018
Co-authors Malcolm Starkey, Peter Gibson, Paul Foster, Jay Horvat
2010 Starkey MR, Horvat JC, Kim RY, Hansbro PM, 'Reply', Journal of Allergy and Clinical Immunology, 125 1415 (2010) [C3]
DOI 10.1016/j.jaci.2010.03.033
Co-authors Malcolm Starkey, Jay Horvat
2010 Wood LG, Hazlewood LC, Foster PS, Hansbro PM, 'Lyprinol reduces inflammation and improves lung function in a mouse model of allergic airways disease', Clinical and Experimental Allergy, 40 1785-1793 (2010) [C1]
DOI 10.1111/j.1365-2222.2010.03503.x
Citations Scopus - 12Web of Science - 9
Co-authors Lisa Wood, Paul Foster
2010 Thorburn AN, Hansbro PM, 'Harnessing regulatory T cells to suppress asthma: From Potential to therapy', American Journal of Respiratory Cell and Molecular Biology, 43 511-519 (2010) [C1]
DOI 10.1165/rcmb.2009-0342TR
Citations Scopus - 36Web of Science - 26
2010 Wood LG, Simpson JL, Hansbro PM, Gibson PG, 'Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia', Free Radical Research, 44 146-154 (2010) [C1]
DOI 10.3109/10715760903362576
Citations Scopus - 32Web of Science - 19
Co-authors Lisa Wood, Jodie Simpson, Peter Gibson
2010 Burgess JK, Boustany S, Moir LM, Weckmann M, Lau JY, Grafton K, et al., 'Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness', American Journal of Respiratory and Critical Care Medicine, 181 106-115 (2010) [C1]
DOI 10.1164/rccm.200904-0631oc
Citations Scopus - 25Web of Science - 18
Co-authors Nicole Hansbro, Paul Foster
2010 Hansbro PM, Warner S, Tracey JP, Arzey KE, Selleck P, O'Riley K, et al., 'Surveillance and analysis of avian influenza viruses, Australia', Emerging Infectious Diseases, 16 1896-1904 (2010) [C1]
DOI 10.3201/eid1612.100776
Citations Scopus - 28Web of Science - 23
2010 Wang W, Li J, Foster PS, Hansbro PM, Yang M, 'Potential therapeutic targets for steroid-resistant asthma', Current Drug Targets, 11 957-970 (2010) [C1]
DOI 10.2174/138945010791591412
Citations Scopus - 26Web of Science - 25
Co-authors Paul Foster, Ming Yang
2009 Thorburn AN, Hansbro PM, Gibson PG, 'Pneumococcal vaccines for allergic airways diseases', Expert Opinion on Biological Therapy, 9 621-629 (2009) [C1]
DOI 10.1517/14712590902916999
Citations Scopus - 15Web of Science - 12
Co-authors Peter Gibson
2009 Haynes L, Arzey E, Bell C, Buchanan N, Burgess G, Cronan V, et al., 'Australian surveillance for avian influenza viruses in wild birds between July 2005 and June 2007', Australian Veterinary Journal, 87 266-272 (2009) [C1]
DOI 10.1111/j.1751-0813.2009.00446.x
Citations Scopus - 31Web of Science - 23
2009 Beagley K, Huston WM, Hansbro PM, Timms P, 'Chlamydial infection of immune cells: Altered function and implications for disease', Critical Reviews in Immunology, 29 275-305 (2009) [C1]
DOI 10.1615/CritRevImmunol.v29.i4.10
Citations Scopus - 41Web of Science - 36
2008 Kaiko GE, Horvat JC, Beagley KW, Hansbro PM, 'Immunological decision-making: How does the immune system decide to mount a helper T-cell response?', Immunology, 123 326-338 (2008) [C1]
DOI 10.1111/j.1365-2567.2007.02719.x
Citations Scopus - 140Web of Science - 118
Co-authors Jay Horvat
2008 Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, Foster PS, Beagley KW, 'Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity', Journal of Immunology, 180 2225-2232 (2008) [C1]
Citations Scopus - 33Web of Science - 29
Co-authors Paul Foster
2008 Asquith KL, Ramshaw HS, Hansbro PM, Beagley KW, Lopez AF, Foster PS, 'The IL-3/IL-5/GM-CSF common beta receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation', Journal of Immunology, 180 1199-1206 (2008) [C1]
Citations Scopus - 65Web of Science - 58
Co-authors Paul Foster
2008 Hansbro NG, Horvat JC, Wark PA, Hansbro PM, 'Understanding the mechanisms of viral induced asthma: New therapeutic directions', Pharmacology & Therapeutics, 117 313-353 (2008) [C1]
DOI 10.1016/j.pharmthera.2007.11.002
Citations Scopus - 62Web of Science - 51
Co-authors Peter Wark, Jay Horvat, Nicole Hansbro
2007 Ashhurst-Smith CIJ, Hall ST, Walker PJ, Stuart JE, Hansbro PM, Blackwell CC, 'Isolation of Alloiococcus otitidis from Indigenous and non-Indigenous Australian children with chronic otitis media with effusion', FEMS Immunology and Medical Microbiology, 51 163-170 (2007) [C1]
DOI 10.1111/j.1574-695X.2007.00297.x
Citations Scopus - 23Web of Science - 18
Co-authors Sharron Hall, John Stuart, Paul Walker, Caroline Blackwell
2007 Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG, Hickey DK, et al., 'Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease', American Journal of Respiratory and Critical Care Medicine, 176 556-564 (2007) [C1]
DOI 10.1164/rccm.200607-1005OC
Citations Scopus - 49Web of Science - 45
Co-authors Peter Gibson, Nicole Hansbro, Jay Horvat, Paul Foster
2007 Preston JA, Essilfie AT, Horvat JC, Wade MA, Beagley KW, Gibson PG, et al., 'Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae', Vaccine, 25 8154-8162 (2007) [C1]
DOI 10.1016/j.vaccine.2007.09.034
Citations Scopus - 30Web of Science - 27
Co-authors Paul Foster, Peter Gibson, Jay Horvat
2006 Skelding KA, Hickey DK, Horvat JC, Bao SS, Roberts KG, Read JM, et al., 'Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection', Vaccine, 24 355-366 (2006) [C1]
DOI 10.1016/j.vaccine.2005.07.104
Citations Scopus - 29Web of Science - 26
Co-authors Kathryn Skelding, Jay Horvat
2006 Hurt AC, Hansbro PM, Selleck P, Olsen B, Minton C, Hampson AW, Barr IG, 'Isolation of avian influenza viruses from two different transhemispheric migratory shorebird species in Australia', Archives of Virology, 151 2301-2309 (2006) [C1]
DOI 10.1007/s00705-006-0784-1
Citations Scopus - 33Web of Science - 27
2006 Gasanov U, Koina CA, Beagley KW, Aitken RJ, Hansbro PM, 'Identification of the insulin-like growth factor II receptor as a novel receptor for binding and invasion by Listeria monocytogenes', Infection and Immunity, 74 566-577 (2006) [C1]
DOI 10.1128/IAI.74.1.566-577.2006
Citations Scopus - 7Web of Science - 5
Co-authors John Aitken
2006 Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS, 'Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity', Clinical and Experimental Allergy, 36 1575-1583 (2006) [C1]
DOI 10.1111/j.1365-2222.2006.02595.x
Citations Scopus - 68Web of Science - 56
Co-authors Paul Foster
2006 Yang M, Mattes J, Hansbro PM, Foster PS, 'Employment of microRNA profiles and RNA interference and antagomirs for the characterization and treatment of respiratory disease', Drug Discovery Today: Therapeutic Strategies, 3 325-332 (2006) [C1]
DOI 10.1016/j.ddstr.2006.10.001
Citations Scopus - 5
Co-authors Paul Foster, Ming Yang, Joerg Mattes
2005 Gasanov U, Hughes D, Hansbro PM, 'Methods for the isolation and identification of Listeria spp. and Listeria monocytogenes: a review', FEMS Microbiology Reviews, 29 851-875 (2005) [C1]
DOI 10.1016/j.femsre.2004.12.002
Citations Scopus - 149Web of Science - 127
2005 Stephenson J, Budd GM, Manning J, Hansbro PM, 'Major eruption-induced changes to the McDonald Islands, southern Indian Ocean', Antarctic Science, 17 259-266 (2005) [C1]
DOI 10.1017/S095410200500266X
Citations Scopus - 2Web of Science - 2
2004 Howland LJ, Hickey DK, Skelding KA, Bao S, Rendina AM, Hansbro PM, et al., 'Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection', Infection and Immunity, 72 1019-1028 (2004) [C1]
DOI 10.1128/IAI.72.2.1019-1028.2004
Citations Scopus - 112Web of Science - 99
Co-authors Kathryn Skelding
2004 Hansbro PM, Beagley KW, Horvat JC, Gibson PG, 'Role of atypical bacterial infection of the lung in predisposition/protection of asthma', Pharmacology and Therapeutics, 101 193-210 (2004) [C1]
DOI 10.1016/j.pharmthera.2003.10.007
Citations Scopus - 66Web of Science - 54
Co-authors Jay Horvat, Peter Gibson
2004 Preston JA, Beagley KW, Gibson PG, Hansbro PM, 'Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia', Eur Respir J, 23 224-231 (2004) [C1]
DOI 10.1183/09031936.03.00081403
Citations Scopus - 21Web of Science - 17
Co-authors Peter Gibson
2002 Badcock D, Hansbro PM, Hanniffy S, Clarke V, Schofield K, Robinson K, et al., 'Identification of Pneumoccal Vaccine Antigens Using a Gram-positive Secretion Reporter Screen in Lactococcus lactis', 3rd International Symposium on Pneumococci and Pneumococcal Diseases, n/a 103 (2002) [C3]
2002 Preston JA, Beagley KW, Gibson PG, Hansbro PM, 'Development of a Pneumococcal Pneumonia Recovery Model in Mice', 3rd International Symposium on Pneumococci and Pneumococcal Diseases, n/a 91 (2002) [C3]
Co-authors Peter Gibson
2001 Preston JA, Beagley KW, Gibson PG, Hansbro PM, 'Effects of Infections by Streptococcus pneumoniae on Eosinophilic Immune Responses', Official Journal of the Australian Society for Microbiology, 22 A82 (2001) [C3]
Co-authors Peter Gibson
2001 Hansbro PM, Wells JM, Le Page RWF, Kyd J, 'Characterisation of a 37 kDa surface protein of Streptococcus pneumoniae that is protective against pneumococcal challenge', Final Program American Society for Microbiology, 101 General Meeting, 101 74 (2001) [C3]
2000 Clark-Walker GD, Hansbro PM, Gibson F, Chen XJ, 'Mutant residues suppressing rho(0)-lethality in Kluyveromyces lactis occur at contact sites between subunits of F-1-ATPase', BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1478 125-137 (2000)
DOI 10.1016/S0167-4838(00)00003-0
Citations Web of Science - 22
1998 Chen XJ, Hansbro PM, Clark-Walker GD, 'Suppression of rho(0) lethality by mitochondrial ATP synthase F-1 mutations in Kluyveromyces lactis occurs in the absence of F-0', MOLECULAR AND GENERAL GENETICS, 259 457-467 (1998)
Citations Web of Science - 14
1998 Hansbro PM, Chen XJ, Clark-Walker GD, 'Allele specific expression of the Mgi(-) phenotype on disruption of the F-1-ATPase delta-subunit gene in Kluyveromyces lactis', CURRENT GENETICS, 33 46-51 (1998)
DOI 10.1007/s002940050307
Citations Web of Science - 6
1995 O'Brien R, Taske N, Hansbro P, Matthaei K, Hogan S, Denborough M, Foster PS, 'Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia', Journal of Medical Genetics, 32 913-914 (1995) [C1]
Citations Scopus - 6Web of Science - 7
Co-authors Paul Foster
1994 Hansbro P, Foster PS, Hogan S, Ozaki S, Denborough M, 'Purification and characterization of D-myo-Inositol (1,4,5)/(1,3,4,5)-polyphosphate 5-phosphatase from skeletal muscle', Archives of Biochemistry and Biophysics, 311 47-54 (1994) [C1]
Citations Scopus - 3Web of Science - 5
Co-authors Paul Foster
1994 Foster PS, Hansbro P, Liu C, Potter B, Denborough M, 'Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism', Biochemical and Biophysical Research Communications, 200 8-15 (1994) [C1]
Citations Scopus - 3Web of Science - 2
Co-authors Paul Foster
1994 Foster PS, Hogan S, Hansbro P, O'Brien R, Potter B, Ozaki S, Denborough M, 'The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle', European Journal of Biochemistry, 222 955-964 (1994) [C1]
Citations Scopus - 12Web of Science - 12
Co-authors Paul Foster
1994 Hogan S, Foster PS, Hansbro P, Ozaki S, Denborough M, 'Detection and partial purification of inositol 1,4,5-trisphosphate 3-kinase from porcine skeletal muscle', Cellular Signalling, 6 233-243 (1994) [C1]
Citations Scopus - 5Web of Science - 4
Co-authors Paul Foster
1992 HANSBRO PM, BYARD SJ, BUSHBY RJ, TURNBULL PJH, BODEN N, SAUNDERS MR, et al., 'THE CONFORMATIONAL BEHAVIOR OF PHOSPHATIDYLINOSITOL IN MODEL MEMBRANES - H-2-NMR STUDIES', BIOCHIMICA ET BIOPHYSICA ACTA, 1112 187-196 (1992)
DOI 10.1016/0005-2736(92)90391-X
Citations Scopus - 24Web of Science - 24
1990 BUSHBY RJ, BYARD SJ, HANSBRO PM, REID DG, 'THE CONFORMATIONAL BEHAVIOR OF PHOSPHATIDYLINOSITOL', BIOCHIMICA ET BIOPHYSICA ACTA, 1044 231-236 (1990)
DOI 10.1016/0005-2760(90)90307-J
Citations Web of Science - 14
1988 SCHORAH CJ, BISHOP N, WALES JK, HANSBRO PM, HABIBZADEH N, 'BLOOD VITAMIN-C CONCENTRATIONS IN PATIENTS WITH DIABETES-MELLITUS', INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 58 312-318 (1988)
Citations Scopus - 14Web of Science - 16
Show 147 more journal articles

Conference (126 outputs)

Year Citation Altmetrics Link
2016 Jones B, Harrison C, Waters D, Dua K, Starkey M, Jarnicki A, et al., 'BROMODOMAIN INHIBITORS REVERSE THE DISEASE FEATURES IN EXPERIMENTAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE', RESPIROLOGY (2016)
Co-authors Peter Wark, Darryl Knight
2016 Horvat J, Kim R, Pinkerton J, Rae B, Starkey M, Essilfie A, et al., 'IDENTIFICATION OF NOVEL THERAPEUTIC TARGETS FOR STEROID-INSENSITIVE ASTHMA USING MODELS THAT REPRESENT DIFFERENT CLINICAL SUBTYPES OF DISEASE', RESPIROLOGY (2016)
Co-authors Jay Horvat, Joerg Mattes, Simon Keely
2016 Gellatly S, Dennis P, Jarnicki A, Lachner N, Wood D, Fricker M, et al., 'HEALTHY GUT MICROBIOTA AMELIORATES EXPERIMENTAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE', RESPIROLOGY (2016)
Co-authors Michael Fricker, Simon Keely
2015 Jones B, Jarnicki A, Smithers N, Knight D, Wark P, Adcock I, Hansbro P, 'EPIGENETIC CHANGES IN HATS AND HDACS DRIVE PATHOGENESIS THAT CAN BE REVERSED USING BET INHIBITORS IN EXPERIMENTAL COPD', RESPIROLOGY (2015) [E3]
Co-authors Darryl Knight, Peter Wark
2015 Tang F, Hansbro P, Burgess J, Baines K, Oliver B, 'NEUTROPHILS DISPLAY IMMUNOREGULATORY ROLES IN RHINOVIRUS INFECTIONS', RESPIROLOGY (2015) [E3]
Co-authors Katherine Baines
2015 Wark P, Tolosa J, Parsons K, Hansbro P, Smith R, 'THE PLACENTAL PROTEIN SYNCYTIN-1 IMPAIRS ANTIVIRAL RESPONSES AND EXAGGERATES INFLAMMATORY RESPONSES TO INFLUENZA', RESPIROLOGY (2015) [E3]
Co-authors Peter Wark, Roger Smith
2015 Kim R, Horvat J, Pinkerton J, Starkey M, Essilfie A, Mayall J, et al., 'INFECTION-INDUCED MICRORNA-21 DRIVES SEVERE, STEROID-INSENSITIVE EXPERIMENTAL ASTHMA BY AMPLIFYING PI3K-MEDIATED SUPPRESSION OF HDAC2', RESPIROLOGY (2015) [E3]
Co-authors Joerg Mattes, Jay Horvat, Simon Keely, Malcolm Starkey, Paul Foster
2015 Tay H, Kaiko G, Plank M, Li J, Essilfie A, Maltby S, et al., 'THE ROLE OF MIR-328 IN RESPIRATORY DISEASES', RESPIROLOGY (2015) [E3]
Co-authors Steven Maltby, Paul Foster, Ming Yang, Joerg Mattes
2015 Hsu A, Parsons K, Hansbro P, Wark P, 'ENHANCED PI3K ACTIVITY LEADS TO DECREASED INTERFERON-beta RESPONSE TO INFLUENZA INFECTION IN COPD', RESPIROLOGY (2015) [E3]
Co-authors Alan Hsu, Peter Wark
2015 Moheimani F, Roth H, Cross J, Reid A, Shaheen F, Warner S, et al., 'SUPPRESSION OF beta-CATENIN/CBP SIGNALING INHIBITS EPITHELIAL-MESENCHYMAL TRANSITION AND MIGRATION OF HUMAN AIRWAY EPITHELIUM', RESPIROLOGY (2015) [E3]
Co-authors Fatemeh Moheimani, Darryl Knight
2015 Loo S, Hsu A, Hansbro P, Wark P, 'THE ROLE OF PI3 KINASE IN INFLUENZA H1N1 AND RHINOVIRUS VIRAL ENTRY INTO PRIMARY BRONCHIAL EPITHELIAL CELLS', RESPIROLOGY (2015) [E3]
Co-authors Peter Wark, Alan Hsu
2015 Mateer S, Marks E, Maltby S, Goggins B, Horvat J, Hansbro P, Keely S, 'Pulmonary retention of PMN attracts primed intestinal lymphocytes in a mouse model of inflammatory bowel disease', FASEB JOURNAL (2015) [E3]
Co-authors Steven Maltby, Jay Horvat, Simon Keely
2015 Harrison C, Essilfee A-T, Jones B, Waters D, Jarnicki A, Hansbro P, 'DEVELOPING A NOVEL MOUSE MODEL OF LUNG CANCER', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2015) [E3]
2015 Tang F, Hansbro P, Burgess J, Baines K, Oliver B, 'A novel immunoregulatory role of neutrophils in viral infections', American Journal of Respiratory and Critical Care Medicine (2015) [E3]
Co-authors Katherine Baines
2014 Mateer S, Maltby S, Marks E, Goggins B, Horvat J, Hansbro P, Keely S, 'Immune cell mis-homing drives secondary organ inflammation in inflammatory bowel disease; a focus on the respiratory system', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014) [E3]
Co-authors Steven Maltby, Jay Horvat, Simon Keely
2014 Hsu A, Parsons K, Fujita T, Hansbro P, Wark P, 'Critical role of PKR in antiviral stress granule and IFN-beta enhanceosome formation, and is impaired in chronic obstructive pulmonary disease', CYTOKINE (2014) [E3]
DOI 10.1016/j.cyto.2014.07.088
Co-authors Alan Hsu, Peter Wark
2014 Hsu A, Parsons K, Hansbro P, Wark P, 'Enhanced PI3K activity leads to decreased IFN-beta response to influenza infection in chronic obstructive pulmonary disease', CYTOKINE (2014) [E3]
DOI 10.1016/j.cyto.2014.07.089
Co-authors Alan Hsu, Peter Wark
2014 Starkey M, Hanish I, Dua K, Nair P, Haw T, Hsu A, et al., 'Interleukin-13 predisposes mice to more severe influenza infection by suppressing interferon responses and activating microRNA-21/PI3K', CYTOKINE (2014) [E3]
DOI 10.1016/j.cyto2014.07.182
Co-authors Paul Foster, Alan Hsu, Darryl Knight, Malcolm Starkey, Peter Wark, Jay Horvat
2014 Horvat J, Kim R, Mayall J, Pinkerton J, Starkey M, Essilfie A, et al., 'ANTIOXIDANT-BASED THERAPY FOR THE SUPPRESSION OF EARLY- LIFE INFECTION-INDUCED SEVERE ASTHMA', RESPIROLOGY (2014) [E3]
DOI 10.1111/resp.12263_2
Co-authors Malcolm Starkey, Lisa Wood, Jay Horvat
2014 Jones B, Hansbro P, 'THE INVOLVEMENT OF HISTONE ACETYLATION ENZYMES IN A MOUSE MODEL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE', RESPIROLOGY (2014) [E3]
2014 Girkin J, Sokulsky L, Hatchwell L, Starkey M, Collison A, Hansbro P, Mattes J, 'IDENTIFICATION OF A NOVEL INTERLEUKIN-13 SIGNALLING PATHWAY', RESPIROLOGY (2014) [E3]
Co-authors Joerg Mattes, Malcolm Starkey
2014 Hsu A, Parsons K, Hansbro P, Wark P, Wark P, 'IMPAIRED FORMATION OF ANTIVIRAL STRESS GRANULE AND INTERFERON-BETA ENHANCEOSOME LEADS TO REDUCED ANTIVIRAL RESPONSES TO INFLUENZA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE', RESPIROLOGY (2014) [E3]
Co-authors Peter Wark, Alan Hsu
2013 Rehaume L, Mondot S, de Carcer DA, Velasco J, Benham H, Hasnain S, et al., 'Host Genetic Background Disrupts The Relationship Between Microbiota and Gut Mucosal Tolerance Leading To Spondyloarthritis and Ileitis After a Dectin-1 Trigger.', ARTHRITIS AND RHEUMATISM (2013) [E3]
2013 Tay H, Kaiko G, Hansbro P, Foster P, 'The role of miRNA in regulating bacterial clearance', JOURNAL OF IMMUNOLOGY (2013) [E3]
Co-authors Paul Foster
2013 Hansbro P, Beckett E, Stevens R, Jarnicki A, Kim R, Hanish I, et al., 'A short-term model of COPD identifies a role for mast cell tryptase', JOURNAL OF IMMUNOLOGY (2013) [E3]
Co-authors Nicole Hansbro, Ming Yang, Peter Wark, Jay Horvat, Paul Foster, Simon Keely
2013 Hansbro P, Horvat J, Essilfie A-T, Kim R, Mayall J, Starkey M, Foster P, 'Macrolides suppress key features of experimental steroid-sensitive and steroid-resistant asthma', JOURNAL OF IMMUNOLOGY (2013) [E3]
Co-authors Paul Foster, Malcolm Starkey, Jay Horvat
2013 Kim RY, Horvat JC, Starkey MR, Essilfie A-T, Foster PS, Hansbro PM, 'MICRORNA INHIBITION IN NEONATAL CHLAMYDIA LUNG INFECTION PREVENTS INFECTION-INDUCED LUNG PATHOLOGY IN LATER LIFE', RESPIROLOGY (2013) [E3]
Co-authors Paul Foster, Jay Horvat, Malcolm Starkey
2013 Horvat JC, Essilfie A-T, Kim RY, Mayall JR, Starkey MR, Beckett EL, et al., 'MACROLIDES SUPPRESS KEY FEATURES OF EXPERIMENTAL STEROID-SENSITIVE AND STEROID-RESISTANT ASTHMA', RESPIROLOGY (2013) [E3]
Co-authors Jay Horvat, Paul Foster, Jodie Simpson, Malcolm Starkey, Peter Gibson
2012 Sobinoff AP, Beckett EL, Nixon B, Roman SD, Hansbro PM, McLaughlin EA, 'The impact of maternal cigarette smoke exposure on the male germline', Abstracts. The Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology 2012 (2012) [E3]
Co-authors Brett Nixon, Eileen Mclaughlin, Shaun Roman
2012 Stifter SA, Fung K, Horvat JC, Hansbro PM, De Weerd NA, Hertzog PJ, 'Expression, purification and biological characterisation of a novel type I interferon, IFN epsilon', Immunology (2012) [E3]
Co-authors Jay Horvat
2012 Kaiko GE, Tay HL, Plank MW, Hansbro PM, Foster PS, 'MicroRNA regulate bacterial phagocytosis in the lung', Immunology: Abstracts of the European Congress of Immunology (2012) [E3]
Co-authors Paul Foster
2012 Starkey M, Kim R, Horvat J, Essilfie A-T, Beagley K, Mattes J, et al., 'Constitutive IL-13 promotes respiratory chlamydial infection and infection-induced chronic airway hyper-responsiveness', JOURNAL OF IMMUNOLOGY (2012) [E3]
Co-authors Joerg Mattes, Paul Foster, Jay Horvat
2012 Mateer S, Hansbro PM, Nolan GM, Chaney C, Minahan KL, Keely S, 'Development of pulmonary inflammation and altered lung function in a mouse model of colitis', Journal of Gastroenterology and Hepatology (2012) [E3]
Co-authors Simon Keely
2012 Horvat JC, Essilfie A-T, Kim RY, Mayall JR, Starkey MR, Beckett EL, et al., 'Efficacy of antibiotic-based therapeutic strategies for the treatment of infection-induced, steroid-resistant allergic airways disease', Respirology (2012) [E3]
Co-authors Malcolm Starkey, Paul Foster, Jay Horvat
2012 Hsu A, Parsons KS, Barr I, Hansbro PM, Wark PA, 'Deficient antiviral responses to influenza in primary bronchial epithelial cells of chronic obstructive pulmonary disease', Respirology (2012) [E3]
Co-authors Alan Hsu, Peter Wark
2012 Plank MW, Kaiko GE, Luck H, Li J, Mattes J, Hansbro PM, Foster PS, 'The role of micrornas in CD4 T cell function', Respirology (2012) [E3]
Co-authors Joerg Mattes, Paul Foster
2012 See HV, Simpson JL, Hansbro PM, Wark PA, 'Stable COPD patients have less rhinovirus-induced intracellular innate cytokines detected in PBMCS compared to healthy adults', Respirology (2012) [E3]
Co-authors Jodie Simpson, Peter Wark
2012 Starkey MR, Kim RY, Horvat JC, Essilfie A-T, Beagley KW, Mattes J, et al., 'Constitutive IL-13 promotes respiratory chlamydial infection-induced chronic airway hyperresponsiveness', Respirology (2012) [E3]
Co-authors Malcolm Starkey, Jay Horvat, Joerg Mattes, Paul Foster
2012 Tay HL, Kaiko GE, Plank MW, Mattes J, Hansbro PM, Foster PS, 'MiRNAs regulate bacterial infection in lungs', Respirology (2012) [E3]
Co-authors Joerg Mattes, Paul Foster
2012 Keely S, Baird A, Kominsky D, McNamee EN, Hansbro PM, Shalwitz RA, Colgan SP, 'Immune modulation by prolyl hydroxylase inhibition contributes to the prevention of endotoxemia in a murine model of inflammatory bowel disease', FASEB Journal (2012) [E3]
Co-authors Simon Keely
2011 O'Reilly M, Hansbro PM, Horvat JC, Sozo F, Harding R, 'Inhalation of hyperoxic gas in the neonatal period has long-term effects on the pulmonary airways', Journal of Developmental Origins of Health and Disease (2011) [E3]
Co-authors Jay Horvat
2011 Foster P, Li J, Wang W, Baines K, Bowden N, Hansbro P, et al., 'IL-27 underpins steroid resistant airway hyperresponsiveness via MyD88 dependent pathways', ALLERGY (2011) [E3]
Co-authors Ming Yang, Nikola Bowden, Peter Gibson
2011 Wynnea O, Horvat JC, Kim RY, Ong LK, Smith R, Hansbro PM, et al., 'Sex differences in the effect of neonatal infection and adult re-infection on hippocampal corticosterone receptors and stress response outcomes', Brain, Behavior, and Immunity (2011) [E3]
Co-authors Roger Smith, Jay Horvat, Linkooi Ong, Deborah Hodgson
2011 O'Reilly M, Harding R, Hansbro PM, Sozo F, 'Exposure to hyperoxic gas in the neonatal period can cause long-term changes in lung function', Journal of Paediatrics and Child Health (2011) [E3]
2011 Foster PS, Tay HL, Kaiko GE, Plank MW, Mattes J, Hansbro PM, 'MiRNA and its roles in regulating bacterial infection in lungs', American Journal of Respiratory and Critical Care Medicine (2011) [E3]
Co-authors Joerg Mattes, Paul Foster
2011 Hansbro PM, Horvat JC, Essilfie A-T, Kim RY, Simpson JL, Dunkley ML, et al., 'Infection-induced neutrophilic allergic airways disease is resistant to steroid treatment', American Journal of Respiratory and Critical Care Medicine (2011) [E3]
Co-authors Margaret Dunkley, Jodie Simpson, Peter Gibson, Jay Horvat, Paul Foster
2011 Horvat JC, Essilfie A-T, Kim RY, Simpson JL, Dunkley ML, Beagley KW, et al., 'Investigation of infection-induced steroid resistant asthma', Respirology (2011) [E3]
Co-authors Jodie Simpson, Peter Gibson, Paul Foster, Jay Horvat, Margaret Dunkley
2011 Oreo K, Baines KJ, Gibson PG, Hansbro PM, 'Pro-inflammatory cytokine production is impaired in response to TLR2 activation in healthy ageing and COPD', Respirology (2011) [E3]
Co-authors Peter Gibson, Katherine Baines
2011 See HV, Simpson JL, Hansbro PM, Wark PA, 'COPD patients PBMCS have an impaired immune response to phinovirus-infected bronchial epithelium', Respirology (2011) [E3]
Co-authors Jodie Simpson, Peter Wark
2010 Hansbro PM, Essilfie A-T, Simpson JL, Dunkley ML, Horvat JC, Gibson PG, Foster PS, 'Haemophilus influenzae induces IL-17-mediated neutrophilic allergic airways disease', American Journal of Respiratory and Critical Care Medicine (2010) [E3]
Citations Scopus - 53Web of Science - 37
Co-authors Paul Foster, Jay Horvat, Margaret Dunkley, Peter Gibson, Jodie Simpson
2010 Thorburn AN, Foster PS, Gibson PG, Hansbro PM, 'Development of a streptococcus pneumoniae-based immunoregulatory therapy for asthma', American Journal of Respiratory and Critical Care Medicine (2010) [E3]
Co-authors Paul Foster, Peter Gibson
2010 Thorburn AN, Foster PS, Gibson PG, Hansbro PM, 'Streptococcus pneumoniae vaccine, prevenar, induces regulatory T cells and prevents allergic airways disease', American Journal of Respiratory and Critical Care Medicine (2010) [E3]
Co-authors Paul Foster, Peter Gibson
2010 O'Reilly M, Harding R, Beckett EL, Horvat JC, Hansbro PM, Sozo F, 'Exposure of the immature mouse lung to hyperoxic gas: do structural changes in the lung cause long-term changes in lung function?', 24th Fetal and Neonatal Physiology Workshop of Australia and New Zealand. Program and Abstracts (2010) [E3]
Co-authors Jay Horvat
2010 Fung K, Cumming H, Mangan N, Horvat JC, Hansbro PM, Hertzog P, 'Interferon epsilon regulates reproductive tract immunity to Chlamydia infection', Journal of Reproductive Immunology (2010) [E3]
Co-authors Jay Horvat
2010 Lam CE, Foo A, Essilfie A-T, Hansbro PM, Matthaei KI, Foster PS, Phipps S, 'Chemerin derived peptide reduces LPS and haemophilus influenza-induced emphysema in mice', Respirology (2010) [E3]
Co-authors Paul Foster
2009 Fung KY, Cumming H, Mangan N, Stifter S, Horvat JC, Hansbro PM, Hertzog PJ, 'Characterisation of a novel, constitutive cytokine that regulates mucosal immunity in the reproductive tract', Cytokine (2009) [E3]
DOI 10.1016/j.cyto.2009.07.324
Co-authors Jay Horvat
2009 Hansbro PM, Starkey MR, Horvat JC, Kim RY, Phipps S, Gibson PG, Foster PS, 'Early life chlamydial infection enhances allergic airways disease through age-dependent differences in immunopathology', Journal of Immunology (2009) [E3]
DOI 10.1016/j.jaci.2009.10.018
Co-authors Peter Gibson, Malcolm Starkey, Paul Foster, Jay Horvat
2009 Hansbro PM, Thorburn AN, Foster PS, Gibson PG, 'Streptococcus pneumoniae vaccine, Prevenar, utilises Tregs to suppress asthma', Journal of Immunology (2009) [E3]
Co-authors Paul Foster, Peter Gibson
2009 Horvat JC, Starkey MR, Beagley KW, Gibson PG, Foster PS, Hansbro PM, 'Chlamydial respiratory infection predisposes to neutrophil dominated allergic airways disease (AAD)', Journal of Immunology (2009) [E3]
Co-authors Malcolm Starkey, Peter Gibson, Paul Foster, Jay Horvat
2009 Wark PA, Hsu A, Hansbro PM, 'Innate immune response of bronchial epithelial cells to infection with influenza', Journal of Immunology (2009) [E3]
Co-authors Peter Wark, Alan Hsu
2009 Wark PA, See HV, Simpson JL, Vanders RL, Hansbro PM, 'Peripheral blood monocytes (PBMCs) display innate antiviral response to rhinovirus (RV) infected bronchial epithelial cells', Journal of Immunology (2009) [E3]
Co-authors Peter Wark, Jodie Simpson
2009 Oldham RA, Simpson JL, Hansbro PM, Gibson PG, 'Increased bacterial load and colonisation in COPD', Respirology (2009) [E3]
DOI 10.1111/j.1440-1843.2009.01503_1.x
Co-authors Jodie Simpson, Peter Gibson
2009 Parsons KS, Gangireddy SR, Hansbro PM, Barr I, Wark PA, 'Response of primary bronchial epithelial cells to infection with human influenza virus', Respirology (2009) [E3]
DOI 10.1111/j.1440-1843.2009.01502_7.x
Co-authors Peter Wark
2009 Thorburn AN, O'Sullivan B, Thomas R, Foster PS, Gibson PG, Hansbro PM, 'Prevenar suppresses allergic airways disease through the expansion of regulatory T cells', Respirology (2009) [E3]
DOI 10.1111/j.1440-1843.2009.01503_1.x
Co-authors Peter Gibson, Paul Foster
2009 Oreo K, Baines KJ, Gibson PG, Hansbro PM, Simpson JL, 'Toll-like receptor agonists stimulate cytokine release from blood but not airway cells', Respirology (2009) [E3]
DOI 10.1111/j.1440-1843.2009.01503_1.x
Co-authors Peter Gibson, Katherine Baines, Jodie Simpson
2009 Essilfie A-T, Simpson JL, Dunkley ML, Foster PS, Gibson PG, Hansbro PM, 'Haemophilus influenzae infection induces features of neutrophilic asthma', Respirology (2009) [E3]
DOI 10.1111/j.1440-1843.2009.01503_1.x
Co-authors Peter Gibson, Jodie Simpson, Margaret Dunkley, Paul Foster
2009 Horvat JC, Starkey MR, Beagley KW, Preston JA, Gibson PG, Foster PS, Hansbro PM, 'Neutrophil influx during chlamydial lung infection determines the phenotype of allergic airways disease (AAD)', Respirology (2009) [E3]
DOI 10.1111/j.1440-1843.2009.01503_1.x
Co-authors Peter Gibson, Malcolm Starkey, Jay Horvat, Paul Foster
2009 Starkey MR, Horvat JC, Kim RY, Phipps S, Gibson PG, Beagley KW, et al., 'Early life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology', Respirology (2009) [E3]
DOI 10.1016/j.jaci.2009.10.018
Citations Scopus - 53Web of Science - 48
Co-authors Malcolm Starkey, Peter Gibson, Paul Foster, Jay Horvat
2009 Hsu A, Hansbro PM, Barr I, Wark PA, 'Innate immune response of bronchial epithelial cells to human and avian influenza virus', Respirology (2009) [E3]
Co-authors Alan Hsu, Peter Wark
2009 Weckmann M, Lau J, Grafton K, Oliver B, Hansbro NG, Foster PS, et al., 'Tumstatin: A non-collagenous domain of collagen IV: Effects on inflammation and angiogenesis', Respirology (2009) [E3]
Co-authors Paul Foster, Nicole Hansbro
2009 Schilter HC, Shum B, Shim D, Maslowski K, Tsai L, Kim R, et al., 'Fatty acid binding proteins: A link between metabolism and airway inflammation?', Respirology (2009) [E3]
Co-authors Nicole Hansbro
2008 Wynne OL, Horvat JC, Smith R, Hansbro PM, Clifton VL, Hodgson DM, 'Impact of neonatal infection on adult hippocampal glucocorticoid receptor, mineralocorticoid receptor and corticotrophin releasing hormone mRNA abundance', Proceedings of the Australian Neuroscience Society (2008) [E3]
Co-authors Roger Smith, Vicki Clifton, Jay Horvat, Olivia Wynne, Deborah Hodgson
2008 Burgess JK, Boustany S, Oliver BG, Moir LM, Baraket M, Hansbro PM, et al., 'The absence of tumstatin in asthma may lead to angiogenesis and airway hyperresponsiveness', American Journal of Respiratory and Critical Care Medicine (2008) [E3]
Co-authors Nicole Hansbro, Paul Foster
2008 Hansbro PM, Essilfie A-T, Foster PS, Gibson PG, 'Haemophilus influenzae (Hi) infection in asthma may drive the development of neutrophilic asthma (NA)', American Journal of Respiratory and Critical Care Medicine (2008) [E3]
Co-authors Peter Gibson, Paul Foster
2008 Hansbro PM, Horvat JC, Beagley KW, Gibson PG, Foster PS, 'Neutrophil influx during chlamydial lung infection determines the phenotype of allergic airways disease', American Journal of Respiratory and Critical Care Medicine (2008) [E3]
Co-authors Peter Gibson, Paul Foster, Jay Horvat
2008 Hansbro PM, Thorburn AN, Foster PS, Gibson PG, 'Streptococcus Pneumoniae vaccine prevenar: A potential therapy for the suppression of asthma', American Journal of Respiratory and Critical Care Medicine (2008) [E3]
Co-authors Paul Foster, Peter Gibson
2008 Simpson JL, Hansbro PM, McDonald VM, Gibson PG, 'Age and disease related changes in airway inflammation and inflammatory subtype in older people with COPD', American Journal of Respiratory and Critical Care Medicine (2008) [E3]
Co-authors Peter Gibson, Jodie Simpson, Vanessa Mcdonald
2008 Thorburn AN, Foster PS, Gibson PG, Hansbro PM, 'Streptococcus pneumoniae vaccine prevenar: A potential therapy for the suppression of asthma', Respirology (2008) [E3]
DOI 10.1111/j.1440-1843.2008.01252.x
Co-authors Paul Foster, Peter Gibson
2008 Horvat JC, Beagley KW, Gibson PG, Foster PS, Hansbro PM, 'Neutrophil influx during chlamydial lung infection determines the phenotype of allergic airways disease', Respirology (2008) [E3]
DOI 10.1111/j.1440-1843.2008.01252.x
Co-authors Paul Foster, Jay Horvat, Peter Gibson
2008 Essilfie A-T, Preston JA, Horvat JC, Dunkley ML, Foster PS, Gibson PG, et al., 'Haemophilus influenzae (Hi) infection in asthma may drive the development of neutrophilic asthma (NA)', Respirology (2008) [E3]
DOI 10.1111/j.1440-1843.2008.01252.x
Co-authors Margaret Dunkley, Peter Gibson, Jodie Simpson, Paul Foster, Jay Horvat
2008 Hansbro NG, Boustany S, Oliver B, Burgess J, Black J, Rosenberg H, et al., 'Early life pneumoviral infection induces the development of pulmonary angiogenesis', Respirology (2008) [E3]
DOI 10.1111/j.1440-1843.2008.01252.x
Co-authors Nicole Hansbro, Paul Foster
2008 Simpson JL, Hansbro PM, McDonald VM, Gibson PG, 'Age and disease related changes in airway inflammation in older people with COPD', Respirology (2008) [E3]
DOI 10.1111/j.1440-1843.2008.01252.x
Co-authors Jodie Simpson, Vanessa Mcdonald, Peter Gibson
2008 Boustany S, Oliver BG, Moir LM, Black JL, Hansbro PM, Hansbro NG, et al., 'Tumstatin, an angiogenic inhibitor, modulates airway angiogenesis', Respirology (2008) [E3]
DOI 10.1111/j.1440-1843.2008.01252_4.x
Co-authors Nicole Hansbro, Paul Foster
2008 Wynne OL, Horvat JC, Smith R, Hansbro PM, Clifton VL, Hodgson DM, 'Impact of neonatal infection on adult hippocampal glucocorticoid receptor and mineralocorticoid receptor abundance', 15th Annual Meeting of the Psychoneuroimmunology Research Society: Program (2008) [E3]
Co-authors Jay Horvat, Olivia Wynne, Roger Smith, Vicki Clifton, Deborah Hodgson
2008 Hansbro PM, Essilfie A-T, Simpson JL, Dunkley ML, Gibson PG, Foster PS, 'Haemophilus influenzae (HI) infection induces features of neutrophilic asthma', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book (2008) [E3]
Co-authors Peter Gibson, Jodie Simpson, Margaret Dunkley, Paul Foster
2008 Hazelwood L, Wood LG, Hansbro PM, Foster PS, 'High fat diet reduces eosinophilic lung inflammation via nicotinic acetylcholine-dependent signaling', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book (2008) [E3]
Co-authors Lisa Wood, Paul Foster
2008 Schilter H, Shim D, Maslowski K, Tsai L, Shum B, Kim RY, et al., 'A role for fatty acid binding proteins in respiratory inflammation', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book (2008) [E3]
Co-authors Nicole Hansbro
2008 Starkey MR, Horvat JC, Kim RY, Phipps S, Gibson PG, Beagley KW, et al., 'Early life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book (2008) [E3]
Co-authors Peter Gibson, Malcolm Starkey, Paul Foster, Jay Horvat
2008 Thorburn AN, O'Sullivan BJ, Thomas R, Foster PS, Gibson PG, Hansbro PM, 'Suppression of allergic airways disease by the Streptococcus pneumoniae vaccine prevenar through the induction of regulatory T cells', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book (2008) [E3]
Co-authors Peter Gibson, Paul Foster
2008 Schilter HC, Shum BOV, Maslowski K, Sewell WA, Hotamisligil GS, Rolph MS, et al., 'Crucial role for fatty acid binding proteins in airway mediated immune responses', Final Programme and Abstracts: World Immune Regulation Meeting II (2008) [E3]
2008 Hsu A, Hansbro PM, Wark PA, 'Innate immune response of bronchial epithelial cells to human and avian influenza virus', The 4th Congress of the Federation of Immunology Societies of Asia-Oceania: Conference Program (2008) [E3]
Co-authors Peter Wark, Alan Hsu
2008 Asquith KL, Ramshaw H, Lopez A, Foster PS, 'The IL-3/IL-5/GM-CSF Common beta Receptor Plays a Pivotal Role in Regulating Th2 Immunity and Allergic Airway Inflammation', FASEB JOURNAL (2008) [E3]
Co-authors Paul Foster
2007 Horvat JC, Preston JA, Gibson PG, Beagley KW, Foster PS, Hansbro PM, 'Development of allergic airways disease (AAD) is differentially affected by the timing of chlamydial infection relative to allergic sensitization', American Journal of Respiratory and Critical Care Medicine (2007) [E3]
Co-authors Peter Gibson, Paul Foster, Jay Horvat
2007 Horvat JC, Garside CG, Wade MA, Preston JA, Hansbro NG, Gibson PG, et al., 'Development of allergic airways disease is differentially affected by chlamydial respiratory infection at different ages', American Journal of Respiratory and Critical Care Medicine (2007) [E3]
Co-authors Jay Horvat, Peter Gibson, Nicole Hansbro, Paul Foster
2007 Hansbro PM, 'Chlamydia pneumoniae and asthma', 2007 National Chlamydia Conference. Program (2007) [E3]
2007 Wark PA, See HV, Oldham R, Timmins N, Gibson PG, Hansbro PM, 'Response by peripheral blood monocytes (PBMCs) to rhinovirus (RV) is greater in cells exposed to infected epithelium in coculture than exposed to RV alone', American Journal of Respiratory and Critical Care Medicine (American Thoracic Society 2007 International Conference Abstracts) (2007) [E3]
Co-authors Peter Gibson, Peter Wark
2007 Wynne OL, Horvat JC, Smith R, Hansbro PM, Clifton VL, Hodgson DM, 'Impact of neonatal infection on adult hippocampal corticosterone receptor abundance and circulating corticosterone', Early Human Development (2007) [E3]
Co-authors Olivia Wynne, Roger Smith, Deborah Hodgson, Jay Horvat, Vicki Clifton
2007 Wynne OL, Horvat JC, Hansbro PM, Clifton VL, Hodgson DM, 'Impact of postnatal stress on neuroendocrine development and function in adulthood in the mouse', Fetal & Neonatal Workshop of Australia and New Zealand 21st Annual Meeting. Abstracts (2007) [E3]
Co-authors Deborah Hodgson, Jay Horvat, Olivia Wynne, Vicki Clifton
2007 Hansbro NG, Boustany S, Oliver BG, Burgess JK, Black JL, Hansbro PM, Foster PS, 'Viral-induced angiogenesis', Immuno 2007: 13th International Congress of Immunology. Abstracts and Posters (2007) [E3]
Co-authors Paul Foster, Nicole Hansbro
2007 Essiflie A, Preston JA, Horvat JC, Dunkley ML, Foster PS, Gibson PG, et al., 'Elucidating the association between Haemophilus influenzae infection and neutrophilic allergic airways disease using mouse models', Immuno 2007: 13th International Congress of Immunology. Abstracts and Posters (2007) [E3]
Co-authors Margaret Dunkley, Jodie Simpson, Peter Gibson, Paul Foster, Jay Horvat
2007 Ferguson AL, Beagley KW, Hansbro PM, Foster PS, 'CD4+ T-cell programming by adult and neonatal bacterial infections inhibit the development of allergic airway inflammation in later life', Immuno 2007: 13th International Congress on Immunology. Abstracts and Posters (2007) [E3]
Co-authors Paul Foster
2007 Horvat JC, Moller CG, Wade MA, Preston JA, Hansbro NG, Gibson PG, et al., 'Allergic airways disease (AAD) is differentially affected by chlamydial lung infection at different stages of life', Respirology (TSANZ Abstracts-Posters) (2007) [E3]
DOI 10.1111/j.1440-1843.2007.001050.x
Co-authors Nicole Hansbro, Peter Gibson, Paul Foster, Jay Horvat
2007 Horvat JC, Preston JA, Gibson PG, Beagley KW, Foster PS, Hansbro PM, 'Timing of chlamydial infection relative to allergen exposure differentially affects allergic airways disease', Respirology (TSANZ Abstracts-Posters) (2007) [E3]
Co-authors Paul Foster, Jay Horvat, Peter Gibson
2007 See H, Oldham R, Timmins N, Hansbro PM, Wark PA, Gibson PG, 'Rhinovirus (RV) induced inflammatory response in mononuclear cells is enhanced by coculture with airway epithelium', Respirology (TSANZ Abstracts-Posters) (2007) [E3]
DOI 10.1111/j.1440-1843.2007.001050.x
Co-authors Peter Wark, Peter Gibson
2007 Simpson JL, Hansbro PM, Kenyon ME, Gibson PG, 'Remodelled asthma in the elderly: is asthma turning into COPD?', Respirology (TSANZ Abstracts-Posters) (2007) [E3]
Co-authors Jodie Simpson, Peter Gibson
2007 Hansbro PM, Warner S, Hurt A, Curran J, 'Carriage of avian influenza viruses by shorebirds in Australia', Sixth Australasian Shorebird Conference 2007: Program and Abstracts (2007) [E3]
2006 Horvat JC, Preston JA, Gibson PG, Beagley KW, Foster PS, Hansbro PM, 'Exacerbation of Allergic Airways Disease (AAD) by Chlamydia is Differentially Affected by the Timing of Infection Relative to Allergen Exposure', Immunology and Cell Biology (2006) [E3]
Co-authors Jay Horvat, Paul Foster, Peter Gibson
2006 Preston JA, Horvat JC, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Streptococcus pneumoniae (SPN) lung infection suppresses hallmark features of a mouse model of asthma', Immunology and Cell Biology (2006) [E3]
Co-authors Paul Foster, Peter Gibson, Jay Horvat
2006 Horvat JC, Moller CG, Wade MA, Preston JA, Hansbro NG, Gibson PG, et al., 'The development of allergic airways disease (AAD) is differently affected by chlamydial lung infection at different stages of life', Immunology and Cell Biology (2006) [E3]
Co-authors Peter Gibson, Paul Foster, Jay Horvat, Nicole Hansbro
2006 Horvat JC, Wade MA, Preston JA, Hansbro NG, Gibson PG, Beagley KW, et al., 'Early life chlamydial lung infection enhances allergic airways disease (AAD)', Respirology (2006) [E3]
Co-authors Nicole Hansbro, Peter Gibson, Paul Foster, Jay Horvat
2006 Preston JA, Horvat JC, Wade MA, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Inhibition of allergic lung disease by respiratory streptococcus pneumoniae infection', Respirology (2006) [E3]
Co-authors Peter Gibson, Jay Horvat, Paul Foster
2006 Horvat JC, Wade MA, Preston JA, Hansbro NG, Gibson PG, Beagley KW, et al., 'Neonatal chlamydial infection exacerbates allergic airways disease', Abstracts ATS 2006 International Conference (2006) [E3]
Co-authors Peter Gibson, Jay Horvat, Paul Foster, Nicole Hansbro
2006 Preston JA, Horvat JC, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Respiratory Streptococcus pneumoniae infection decreases key inflammatory responses in a mouse model of asthma', Abstracts ATS 2006 International Conference (2006) [E3]
Co-authors Jay Horvat, Paul Foster, Peter Gibson
2006 Gadil E, Morris PS, Beissbarth J, Chang A, Gibson PG, Hare K, et al., 'Use of ototopical antibiotic treatment on chronic suppurative otitis media: A randomized placebo controlled trial and feasibility study', 5th International Symposim on Pneumoccoci and Pneumococcal Diseases (2006) [E3]
Co-authors Peter Gibson
2006 Preston JA, Horvat JC, Wade MA, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Inhibition of allergic lung disease by respiratory Streptococcus pneumoniae infection', 5th International Symposium on Pneumococci and Pneumococcal Diseases (2006) [E3]
Co-authors Peter Gibson, Jay Horvat, Paul Foster
2006 Preston JA, Horvat JC, Wade MA, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'The influence of allergic airways disease on the immune response to respiratory Streptococcus pneumoniae infection', 5th International Symposium on Pneumococci and Pneumococcal Diseases (2006) [E3]
Co-authors Jay Horvat, Peter Gibson, Paul Foster
2005 Preston JA, Horvat JC, Wade MA, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Respiratory streptococcus pneumoniae infection decreases key inflammatory responses in a mouse model of asthma', TISSUE ANTIGENS (2005)
Co-authors Jay Horvat, Paul Foster, Peter Gibson
2005 Horvat JC, Wade MA, Preston JA, Newcombe N, Ferguson AL, Kaiko G, et al., 'Neonatal But Not Adult Chlamydial Infection Induces the Development of Allergic Airways Disease Through Novel Mechanisms Involving Inflammation of Mixed Phenotype', Tissue Antigens (2005) [E3]
Citations Web of Science - 1
Co-authors Jay Horvat, Paul Foster, Peter Gibson
2005 Horvat JC, Preston JA, Hansbro NG, Ferguson AL, Gibson PG, Beagley KW, et al., 'Neonatal chlamydial infection inhibits the development of allergic airway inflammation in adult mice', Inflammation Research (2005) [E3]
Co-authors Nicole Hansbro, Peter Gibson, Jay Horvat, Paul Foster
2005 Wynne OL, Clifton VL, Murphy VE, Hodyl NA, Krivanek K, Smith D, et al., 'The Effects of Prenatal Endotoxin Exposure on Placental 11-HSD2 Activity and the Developing HPA Axis in the Fischer 344 Rat', Australian Neuroscience Society: Proceedings of the 25th Annual (2005) [E3]
Co-authors Vicki Clifton, Deborah Hodgson, Olivia Wynne, Vanessa Murphy
2005 Preston JA, Horvat JC, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Timing of Streptococcus Pneumoniae (pnc) infection determines the magnitute of the effect on allergic airways inflammation (AAI) in a mouse model of asthma', Respirology (2005) [E3]
Co-authors Paul Foster, Jay Horvat, Peter Gibson
2005 Preston JA, Horvat JC, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Respiratory Streptococcus Pneumoniae Infection Decreases Eosinophilia and Mucus Cell Hyperplasia in a Mouse Model of Asthma', Respirology (2005) [E3]
Co-authors Jay Horvat, Paul Foster, Peter Gibson
2005 Hurt AC, Hansbro PM, Selleck P, Olsen B, Barr IG, Hampson AW, 'Isolation of Avian Influenza Viruses from two different Transhemispheric migratory shorebird Species in Australia', Australian Virology Group (2005) [E3]
2005 Skelding KA, Hickey DK, Horvat JC, Hansbro PM, Bao S, Beagley KW, 'Combined transcutaneous and intranasal immunisation protects against genital tract Chlamydial infection', Proceedings of the Twelfth International Congress of Mucosal Immunology (2005) [E3]
Co-authors Kathryn Skelding, Jay Horvat
2005 Skelding KA, Hickey DK, Horvat JC, Hansbro PM, Bao S, Beagley KW, 'Comparison of intranasal and transcutaneous immunisation for the protection against Chlamydial pneumonia', Proceedings of the Twelfth International Congress of Mucosal Immunology (2005) [E3]
Co-authors Jay Horvat, Kathryn Skelding
2003 Berry L, Hickey DK, Skelding KA, Bao S, Hansbro PM, Beagley KW, 'Transcutaneous immunisation prevents Chlamydia muridarum genital tract infection', American Journal of Reproductive Immunology (2003) [E3]
Co-authors Kathryn Skelding
Show 123 more conferences

Patent (3 outputs)

Year Citation Altmetrics Link
2008 Hansbro PM, Gibson PG, Vaccine compositions (2008) [I3]
Co-authors Peter Gibson
2007 Gibson PG, Hansbro PM, Treatment and prevention of allergic airways diseases (2007) [I3]
Co-authors Peter Gibson
2001 Hanniffy SB, Hansbro PM, Wells JM, Le Page RW, Lactococcal expression of exported protein-based discovery of Streptococcus pneumoniae genes encoding surface proteins. (2001) [I1]

Report (1 outputs)

Year Citation Altmetrics Link
2008 Kirkland PD, Arzey KE, Tracey J, Hansbro PM, Rose K, 'Surveillance of wild birds in NSW for avian influenze viruses. Report to the Department of Agriculture, Fisheries and Forestry', NSW Department of Primary Industries, 15 (2008) [R2]
Edit

Grants and Funding

Summary

Number of grants 148
Total funding $20,485,772

Click on a grant title below to expand the full details for that specific grant.


20169 grants / $2,150,774

Role and potential for therapeutic targeting of dysfunction, oxidative stress and altered metabolism in mitochondria in the pathogenesis of COPD$720,338

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Conjoint Professor Peter Wark, Professor Ian Adcock, Professor Luke O'Neill
Scheme Project Grant
Role Lead
Funding Start 2016
Funding Finish 2019
GNo G1500070
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Identification of genomic mutations associated with the development and progression of lung cancer for use in early diagnosis$360,000

Funding body: Cancer Council NSW

Funding body Cancer Council NSW
Project Team Professor Phil Hansbro, Conjoint Professor Peter Wark, Professor David Watkins, Dr Warren Kaplan
Scheme Research Grant
Role Lead
Funding Start 2016
Funding Finish 2018
GNo G1500465
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Investigation and therapeutic targeting of the immune mechanisms that predispose to and increase the severity of influenza in pregnancy$309,436

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Ms Rebecca Vanders, Professor Phil Hansbro
Scheme Early Career Fellowships
Role Investigator
Funding Start 2016
Funding Finish 2019
GNo G1400642
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Investigate the role of mast cells in disease$300,000

Funding body: St George & Sutherland Medical Research Foundation

Funding body St George & Sutherland Medical Research Foundation
Project Team Professor Phil Hansbro, Professor Richard Stevens, Professor Steven Krilis
Scheme Capacity Building Grant
Role Lead
Funding Start 2016
Funding Finish 2017
GNo G1501132
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

The pneumococcal vaccine Prevenar 13 as a new asthma therapy$180,000

Funding body: Asthma Australia

Funding body Asthma Australia
Project Team Conjoint Professor Peter Gibson, Professor Phil Hansbro
Scheme National Research Program
Role Investigator
Funding Start 2016
Funding Finish 2018
GNo G1500725
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Elucidating and targeting genomic and epigenetic changes in the development and progression of lung cancer$160,000

Funding body: Lung Foundation Australia

Funding body Lung Foundation Australia
Project Team Professor Phil Hansbro, Fellowship
Scheme Early Career Fellowship for Lung Cancer Research
Role Lead
Funding Start 2016
Funding Finish 2017
GNo G1600599
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

To assess the efficacy of Allakos compounds in murine model of cigarette smoke-induced COPD$68,000

Funding body: Allakos Inc

Funding body Allakos Inc
Project Team Professor Phil Hansbro
Scheme Research Consultancy
Role Lead
Funding Start 2016
Funding Finish 2016
GNo G1600869
Type Of Funding International - Non Competitive
Category 3IFB
UON Y

MD990 Respiratory Project$48,000

Funding body: AusBio Limited

Funding body AusBio Limited
Project Team Professor Phil Hansbro
Scheme Research Project
Role Lead
Funding Start 2016
Funding Finish 2016
GNo G1600515
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Targeting to Fibulin-1 as a novel therapeutic option for IPF$5,000

Funding body: Lung Foundation Australia

Funding body Lung Foundation Australia
Project Team Professor Phil Hansbro, Mr Gang Liu
Scheme Research Award
Role Lead
Funding Start 2016
Funding Finish 2016
GNo G1600702
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20159 grants / $2,495,212

Modifying epigenetics as a novel treatment in COPD$1,076,254

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Professor Darryl Knight, Conjoint Professor Peter Wark, Professor Ian Adcock
Scheme Project Grant
Role Lead
Funding Start 2015
Funding Finish 2019
GNo G1400006
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Development of new therapies for respiratory diseases and infection$828,300

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro
Scheme Research Fellowships
Role Lead
Funding Start 2015
Funding Finish 2019
GNo G1400019
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Elucidating the post-transcriptional regulation of mast cell proteases$443,900

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Professor Phil Hansbro, Professor Richard Stevens, Professor Paul Hertzog
Scheme Discovery Projects
Role Lead
Funding Start 2015
Funding Finish 2017
GNo G1400517
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Nose only inhalation smoke exposure system for mice$54,698

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Doctor Jay Horvat, Doctor Janet Bristow, Doctor Malcolm Starkey, Ms Rebecca Vanders
Scheme Equipment Grant
Role Lead
Funding Start 2015
Funding Finish 2015
GNo G1501551
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Characterising the airway and gut microbiome in severe asthma$25,222

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Associate Professor Jodie Simpson, Conjoint Associate Professor Nick Saltos, Professor Phil Hansbro
Scheme Research Grant
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo G1500009
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Investigation of the progression of Alzheimers Disease: Identification of potential drivers of disease$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Jay Horvat, Associate Professor Liz Milward, Professor Phil Hansbro, Dr Daniel Johnstone
Scheme Project Grant
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo G1500589
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

How oxidative stress makes severe asthmatics susceptible to infection with Rhinovirus$20,000

Funding body: National Clinical CRE in Severe Asthma

Funding body National Clinical CRE in Severe Asthma
Project Team Conjoint Professor Peter Wark, Associate Professor Lisa Wood, Professor Phil Hansbro, Mr Prabuddha Pathinayake
Scheme Seed Research Project
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo G1600355
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Assessing the potential of a new therapeutic for COPD$16,838

Funding body: Boston University

Funding body Boston University
Project Team Professor Phil Hansbro, Dr Avi Spira
Scheme Research Grant
Role Lead
Funding Start 2015
Funding Finish 2017
GNo G1501125
Type Of Funding International - Non Competitive
Category 3IFB
UON Y

Greaves Family Postgraduate Scholarship in Medical Research$10,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Jay Horvat, Doctor Richard Kim, Mr James Pinkerton, Professor Phil Hansbro
Scheme Postgraduate Research Scholarship
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo G1501396
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

201412 grants / $3,122,160

Altering the microbiome to treat COPD$1,179,568

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Professor Philip Hugenhotlz, Professor Matthew Cooper
Scheme Project Grant
Role Lead
Funding Start 2014
Funding Finish 2018
GNo G1300064
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Interferon epsilon for Chlamydia RTIs $729,817

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Doctor Jay Horvat, Professor Paul Hertzog
Scheme Project Grant
Role Lead
Funding Start 2014
Funding Finish 2017
GNo G1300071
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

A novel approach to understanding Asthma: Focus on the epithelium $617,209

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Darryl Knight, Professor Phil Hansbro, Professor Stephen Stick, Dr Anthony Kicic
Scheme Project Grant
Role Investigator
Funding Start 2014
Funding Finish 2017
GNo G1300212
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Investigating the role of microbiomes in COPD$360,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Phil Hansbro
Scheme Project Grant
Role Lead
Funding Start 2014
Funding Finish 2016
GNo G1400891
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

The Nanostring nCounter System$75,000

Funding body: Ramaciotti Foundations

Funding body Ramaciotti Foundations
Project Team Professor Darryl Knight, Professor Phil Hansbro, Laureate Professor Paul Foster, Professor Rodney Scott, Conjoint Professor Peter Gibson, Professor Michael Nilsson
Scheme Major Equipment Award
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1300853
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

High Throughput Cell Genomics Centre$50,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Paul Hertzog, Professor James Whisstock, Professor Fabienne Mackay, Professor William Charman, Dr Jose Polo, Professor Elizabeth Hartland, Professor Martin Pera, Professor Phil Hansbro
Scheme Equipment Grant
Role Lead
Funding Start 2014
Funding Finish 2014
GNo G1300642
Type Of Funding Internal
Category INTE
UON Y

The Nanostring nCounter System$40,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Darryl Knight, Professor Phil Hansbro, Laureate Professor Paul Foster, Professor Rodney Scott, Conjoint Professor Peter Gibson, Professor Michael Nilsson
Scheme Equipment Grant
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1301083
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Miltenyi Biotec GentleMACS Octo Dissociator with Heaters $23,566

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Professor Darryl Knight, Professor Dirk Van Helden, Professor Joerg Mattes, Associate Professor Jodie Simpson, Associate Professor Lisa Wood, Associate Professor Liz Milward, Dr NATHAN Bartlett, Doctor Simon Keely, Doctor Steven Maltby, Doctor Andrew Jarnicki, Doctor Malcolm Starkey, Doctor Adam Collison, Ms Shaan Gellatly
Scheme Equipment Grant
Role Lead
Funding Start 2014
Funding Finish 2014
GNo G1500861
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

The Nanostring nCounter System$20,000

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Professor Darryl Knight, Professor Phil Hansbro, Laureate Professor Paul Foster, Professor Rodney Scott, Conjoint Professor Peter Gibson, Professor Michael Nilsson
Scheme Research Grant
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1301084
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

HMRI Award for Research Excellence$15,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Phil Hansbro
Scheme Sparke Helmore/NBN Television Corporate Triathlon Award for Research Excellence
Role Lead
Funding Start 2014
Funding Finish 2014
GNo G1301343
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

2014 International Visitor from Imperial College London, UK$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro, Professor Ian Adcock
Scheme International Research Visiting Fellowship
Role Lead
Funding Start 2014
Funding Finish 2014
GNo G1400869
Type Of Funding Internal
Category INTE
UON Y

American Thoracic Society, San Diego USA, 17-21 May 2014$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2014
Funding Finish 2014
GNo G1400567
Type Of Funding Internal
Category INTE
UON Y

20136 grants / $588,552

Enhancing innate immune responses to influenza in chronic obstructive pulmonary disease$504,552

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor Peter Wark, Professor Phil Hansbro, Professor James Mahony
Scheme Project Grant
Role Investigator
Funding Start 2013
Funding Finish 2015
GNo G1200206
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Whitley DG250 Workstation – Anaerobic Incubator; MouseOxPlus® 230V – Pulse Oximeter for mice, rats, and other small laboratory animals$30,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro
Scheme Equipment Grant
Role Lead
Funding Start 2013
Funding Finish 2014
GNo G1301307
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Protecting Pregnant Women from Death during influenza epidemics$25,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Laureate Professor Roger Smith, Professor Phil Hansbro, Conjoint Professor Peter Wark
Scheme Project Grant
Role Investigator
Funding Start 2013
Funding Finish 2013
GNo G1301181
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

DP73 Digital colour and monochrome camera + cellSens software + Xcite120 fluorescence lamp illuminator$20,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Laureate Professor Paul Foster, Doctor Alan Hsu, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Katie Baines, Associate Professor Jodie Simpson, Professor Rakesh Kumar, Doctor Nicole Hansbro, Doctor Steven Maltby, Doctor Ming Yang, Doctor Gerard Kaiko, Doctor Jay Horvat, Doctor Simon Keely, Doctor Andrew Jarnicki, Doctor Michael Fricker
Scheme Equipment Grant
Role Investigator
Funding Start 2013
Funding Finish 2013
GNo G1201186
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Australia-Harvard Fellowship$7,000

Funding body: Harvard Club of Australia Foundation

Funding body Harvard Club of Australia Foundation
Project Team Professor Phil Hansbro
Scheme Australia-Harvard Fellowships
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300903
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

International Congress of Immunology European Respiratory Society. 22-27 Aug 13 & 7-11 Sep 13$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300797
Type Of Funding Internal
Category INTE
UON Y

20128 grants / $801,879

Elucidating the role of mast cell tryptases in chronic obstructive pulmonary disease and Crohn's disease$609,879

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Laureate Professor Nick Talley, Dr Brian Oliver
Scheme Project Grant
Role Lead
Funding Start 2012
Funding Finish 2014
GNo G1100239
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

SpectraMax M5e Multi-Mode Microplate Reader$50,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Laureate Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Professor Rakesh Kumar, Doctor Nicole Hansbro, Doctor Ming Yang, Doctor Jay Horvat, Doctor Simon Keely, Doctor Andrew Jarnicki, Doctor Linda Howland, Doctor Kelly Asquith
Scheme Equipment Grant
Role Investigator
Funding Start 2012
Funding Finish 2012
GNo G1100975
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Emphysema Research$50,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Special Project Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1201088
Type Of Funding Internal
Category INTE
UON Y

Novel strategies to boost tristetraprolin function: a critical anti-inflammatory protein in asthma$30,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Associate Professor Alaina Ammit, Associate Professor Andrew Clark, Professor Phil Hansbro
Scheme Project Grant
Role Lead
Funding Start 2012
Funding Finish 2014
GNo G1200372
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

COPD-induced systemic inflammation activates mast cell specific tryptases which lead to cardiovascular disease $25,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Phil Hansbro, Doctor Andrew Jarnicki
Scheme Research Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200028
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Coordinated targeting of immune pathways to suppress infection-associated inflammatory diseases.$20,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro, Professor Joerg Mattes
Scheme Near Miss Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200671
Type Of Funding Internal
Category INTE
UON Y

Elucidating the mechanisms of steroid-resistant asthma$15,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Jay Horvat, Professor Phil Hansbro, Laureate Professor Paul Foster
Scheme Research Grant
Role Investigator
Funding Start 2012
Funding Finish 2012
GNo G1200190
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

American Thoracic Society, San Francisco, 18 - 23 May 2012$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200498
Type Of Funding Internal
Category INTE
UON Y

201111 grants / $2,289,735

Identifying new therapeutic targets for preventing the induction and progression of COPD$626,732

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Conjoint Professor Peter Wark
Scheme Project Grant
Role Lead
Funding Start 2011
Funding Finish 2013
GNo G1000252
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Understanding the mechanisms of respiratory viral infection- and COPD-induced predisposition to secondary bacterial pneumonia $573,390

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Conjoint Professor Peter Wark
Scheme Project Grant
Role Lead
Funding Start 2011
Funding Finish 2013
GNo G1000248
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

A novel reproductive tract factor that protects against chlamydia$522,456

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Professor Paul Hertzog
Scheme Project Grant
Role Lead
Funding Start 2011
Funding Finish 2013
GNo G1000251
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Development of microbial bioproducts for the suppression of inflammation$285,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Professor Rakesh Kumar
Scheme Discovery Projects
Role Lead
Funding Start 2011
Funding Finish 2013
GNo G1000021
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Research microscope, confocal ready nikon eclipse 90i microscope$69,157

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Laureate Professor Roger Smith, Conjoint Professor Tamas Zakar, Professor Jon Hirst, Doctor Kaushik Maiti, Doctor Gemma Madsen, Professor Rodney Scott, Conjoint Professor Peter Wark, Laureate Professor Paul Foster, Professor Phil Hansbro, Conjoint Professor Ian Wright
Scheme Equipment Grant
Role Investigator
Funding Start 2011
Funding Finish 2011
GNo G1100024
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

DVCR Special Equipment Grant 2011$66,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Special Project (Equipment) Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1101126
Type Of Funding Internal
Category INTE
UON Y

Maitland Cancer Appeal Committee Donation - Lung Cancer Mouse Model$50,000

Funding body: Maitland Cancer Appeal Committee

Funding body Maitland Cancer Appeal Committee
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Doctor Gough Au
Scheme Research Project
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1100246
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

SCIREQ FlexiVentFX system + FlexiVentFX extension$45,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Professor Joerg Mattes, Doctor Simon Keely, Doctor Jay Horvat, Doctor Nicole Hansbro, Doctor Ming Yang, Doctor Catherine Ptaschinski, Doctor Kelly Asquith, Doctor Gough Au, Conjoint Professor Peter Wark, Laureate Professor John Aitken, Conjoint Professor Keith Jones, Laureate Professor Roger Smith, Professor Judith Black, Professor Rakesh Kumar, Professor Paul Hertzog
Scheme Equipment Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1100037
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Streptococcus pneumoniae-based immunoregulatory therapy for asthma$35,000

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Professor Phil Hansbro
Scheme Innovation Grants
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1000788
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Antioxidant therapies for suppressing infection-induced asthma in children$15,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Jay Horvat, Associate Professor Lisa Wood, Professor Phil Hansbro
Scheme Youth Research Project Grant
Role Investigator
Funding Start 2011
Funding Finish 2011
GNo G1001002
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

American Thoracic Society, Colorado Convention Centre, 15 - 18 May 2010$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1100298
Type Of Funding Internal
Category INTE
UON Y

20104 grants / $107,500

Refining Streptococcus pneumoniae-based immunoregulatory therapy to suppress asthma$44,500

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Professor Phil Hansbro, Professor Rakesh Kumar
Scheme Research Grant
Role Lead
Funding Start 2010
Funding Finish 2010
GNo G0900076
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Buxco FinePointe software and FinePointe RC system for mice $39,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Laureate Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Nicole Hansbro, Doctor Simon Phipps, Doctor Ming Yang, Doctor Kelly Asquith, Doctor Catherine Ptaschinski, Professor Rakesh Kumar, Professor Judith Black
Scheme Equipment Grant
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G1000053
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Targeting CXCR7 for fibrosis$22,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro
Scheme Development Grants
Role Lead
Funding Start 2010
Funding Finish 2010
GNo G1000682
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

American Thoracic Society, New Orleans, 14 - 19th May 2010$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2010
Funding Finish 2010
GNo G1000126
Type Of Funding Internal
Category INTE
UON Y

20098 grants / $1,266,230

Mechanisms and treatment of early life chlamydial infection and associated asthma$592,125

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Professor Kenneth Beagley, Professor Joerg Mattes
Scheme Project Grant
Role Lead
Funding Start 2009
Funding Finish 2011
GNo G0188845
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

The Development of New and Effective Immunotherapies for Asthma$45,455

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Professor Phil Hansbro
Scheme Asthma Research Sustainability Grant
Role Lead
Funding Start 2009
Funding Finish 2009
GNo G0189728
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Coulter counter$41,150

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Laureate Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Simon Phipps, Doctor Ming Yang, Doctor Nicole Hansbro, Doctor Kelly Asquith
Scheme Equipment Grant
Role Investigator
Funding Start 2009
Funding Finish 2009
GNo G0189851
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Immunisation against chlamydia-associated asthma$20,000

Funding body: Rebecca L Cooper Medical Research Foundation Ltd

Funding body Rebecca L Cooper Medical Research Foundation Ltd
Project Team Doctor Jay Horvat, Professor Phil Hansbro, Laureate Professor Paul Foster
Scheme Research Grant
Role Investigator
Funding Start 2009
Funding Finish 2009
GNo G0189629
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Prevention and treatment of asthma using streptococcus pneumoniae-based immunomododulatory therapy$20,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Near Miss Grant
Role Lead
Funding Start 2009
Funding Finish 2009
GNo G0189815
Type Of Funding Internal
Category INTE
UON Y

American Association of Immunologists and American Thoracic Society, Seattle USA, 8-12 May 2009$2,500

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2009
Funding Finish 2009
GNo G0189963
Type Of Funding Internal
Category INTE
UON Y

20085 grants / $502,150

The mechanisms of infection of bronchial epithelial cells by human & avian influenza viruses in chronic airways disease$379,650

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor Peter Wark, Professor Phil Hansbro, Dr Ian Barr
Scheme Project Grant
Role Investigator
Funding Start 2008
Funding Finish 2010
GNo G0187593
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

The use of the components of the bacteria, streptococcus pneumoniae, as novel immunotherapies for asthma$50,000

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Professor Phil Hansbro, Professor Rakesh Kumar, Conjoint Professor Peter Wark
Scheme Research Grant
Role Lead
Funding Start 2008
Funding Finish 2008
GNo G0188434
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

Individually ventilated cages (IVC) and associated ventilator, holding boxes and water bottles$35,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Laureate Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Simon Phipps, Doctor Ming Yang, Doctor Nicole Hansbro, Doctor Kelly Asquith
Scheme Equipment Grant
Role Investigator
Funding Start 2008
Funding Finish 2008
GNo G0188541
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Becton Dickinson high throughout sampler for the FACSCanto II cytometry system$35,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor Peter Wark, Conjoint Professor Peter Gibson, Associate Professor Jodie Simpson, Associate Professor Lisa Wood, Doctor Vanessa Murphy, Professor Phil Hansbro
Scheme Equipment Grant
Role Investigator
Funding Start 2008
Funding Finish 2008
GNo G0188547
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

American Thoracic Society, Metro Toronto Convention Centre, 16/5/2008 - 21/5/2008$2,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2008
Funding Finish 2008
GNo G0188983
Type Of Funding Internal
Category INTE
UON Y

200720 grants / $1,273,050

Characterisation and Treatment of Innate Immune Dysfunction in Older People with Obstructive Airway Disease$416,875

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Associate Professor Jodie Simpson, Conjoint Professor Peter Gibson, Professor Phil Hansbro
Scheme Project Grant
Role Investigator
Funding Start 2007
Funding Finish 2009
GNo G0186426
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Viruses, Infection/Immunology, vaccines and Asthma, Hunter medical Research Institute$230,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team

P G Gibson

Scheme Research Infrastructure
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON N

Surveillance of wild birds for avian influenza viruses in NSW$191,524

Funding body: Department of Agriculture, Fisheries and Forestry Australia

Funding body Department of Agriculture, Fisheries and Forestry Australia
Project Team Dr Peter Kirkland, Professor Phil Hansbro
Scheme New Industries Development Programme
Role Lead
Funding Start 2007
Funding Finish 2016
GNo G0186812
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Investigation of chlamydial infection and asthma$68,000

Funding body: Faculty of Health

Funding body Faculty of Health
Project Team

Phil Hansbro

Scheme Postdoctoral Award
Role Lead
Funding Start 2007
Funding Finish 2007
GNo
Type Of Funding Internal
Category INTE
UON N

In vitro response of bronchial epithelial cells and activation of lymphocytes to infection with rhinovirus$58,848

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Conjoint Professor Peter Wark, Professor Phil Hansbro, Associate Professor Jodie Simpson
Scheme Research Grant
Role Investigator
Funding Start 2007
Funding Finish 2009
GNo G0188095
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

Prevention of heart disease by pneumococcal vaccination$50,000

Funding body: Pfizer Australia

Funding body Pfizer Australia
Project Team Professor Phil Hansbro, Dr Sukumaran Thambar, Professor John Attia, Associate Professor Mark McEvoy
Scheme Cardiovascular Lipid Research Grants
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0186642
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

Nitric Oxide Monitoring System (NIOX)$45,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor Peter Gibson, Conjoint Associate Professor Vicki Clifton, Conjoint Professor Warwick Giles, Emeritus Professor Michael Hensley, Doctor Vanessa Murphy, Conjoint Professor Peter Wark, Associate Professor Vanessa McDonald, Associate Professor Jodie Simpson, Conjoint Associate Professor Bruce Whitehead, Laureate Professor Paul Foster, Professor Phil Hansbro, Associate Professor Lisa Wood
Scheme Equipment Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0188193
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

In vitro response of bronchial epithelial cells and activation of lymphocytes from COPD patients by infection with rhinovirus, respiratory syncytial virus and haemophilus influenza$25,000

Funding body: GlaxoSmithKline Australia

Funding body GlaxoSmithKline Australia
Project Team Conjoint Professor Peter Wark, Professor Phil Hansbro, Associate Professor Jodie Simpson
Scheme Support Grant
Role Investigator
Funding Start 2007
Funding Finish 2008
GNo G0188309
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Prevention and treatment of asthma by bacterial vaccination$22,500

Funding body: CRC for Asthma and Airways

Funding body CRC for Asthma and Airways
Project Team

Alison Thorburn

Scheme Unknown
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON N

Elucidation of the association between Haemophilus influenzae infection and neutrophilic asthma.$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Phil Hansbro, Associate Professor Jodie Simpson, Laureate Professor Paul Foster, Conjoint Professor Margaret Dunkley
Scheme Project Grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0187206
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

The role of tumstatin in angiogenesis and asthma$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Laureate Professor Paul Foster, Doctor Nicole Hansbro, Doctor Simon Phipps, Professor Phil Hansbro
Scheme Project Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0187238
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Hewlett Packard 7890 series gas chromatograph with accessories$20,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Associate Professor Lisa Wood, Conjoint Professor Peter Wark, Conjoint Professor Peter Gibson, Associate Professor Jodie Simpson, Doctor Vanessa Murphy, Laureate Professor Paul Foster, Professor Phil Hansbro, Conjoint Associate Professor Vicki Clifton, Professor Clare Collins, Conjoint Professor Wayne Smith, Professor John Attia
Scheme Equipment Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0188191
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Class II biohazard containment hood and carbon dioxide cell culture incubator$20,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor Peter Wark, Conjoint Professor Peter Gibson, Associate Professor Jodie Simpson, Doctor Vanessa Murphy, Associate Professor Lisa Wood, Laureate Professor Paul Foster, Professor Phil Hansbro
Scheme Equipment Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0188192
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Prevention of asthma by antibiotic treatment/vaccination against chlamydia$20,000

Funding body: Rebecca L Cooper Medical Research Foundation Ltd

Funding body Rebecca L Cooper Medical Research Foundation Ltd
Project Team

Phil Hansbro

Scheme Research Award
Role Lead
Funding Start 2007
Funding Finish 2007
GNo
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON N

The prevention and treatment of Asthma with a diet high in seafood content$15,525

Funding body: Seafood Services Australia

Funding body Seafood Services Australia
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster
Scheme Seafood Industry Development Fund
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0185404
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

Miccroarrays to identify novel therapeutic targets for bird flu$14,500

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Conjoint Professor Peter Wark, Professor Phil Hansbro
Scheme Research Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0187337
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Microarrays to identify novel therapeutic targets for bird flu$14,500

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team

Peter Wark

Scheme Research Award
Role Lead
Funding Start 2007
Funding Finish 2007
GNo
Type Of Funding Other Public Sector - Local
Category 2OPL
UON N

BioSafety Cabinet$10,778

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Phil Hansbro
Scheme Equipment Grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0188049
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

The association between Chlamydial infection and asthma$7,500

Funding body: CRC for Asthma and Airways

Funding body CRC for Asthma and Airways
Project Team

Jay Horvat

Scheme Research Scholars Award
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON N

International Congress on Immunology, Riocentro, Rio de Janeiro, 20/8/2007 - 24/8/2007$2,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0187944
Type Of Funding Internal
Category INTE
UON Y

200615 grants / $1,955,769

PRC Priority Research Centre for Asthma & Respiratory Diseases$524,282

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Laureate Professor Paul Foster, Conjoint Professor Peter Gibson, Conjoint Professor Kenneth Beagley, Emeritus Professor Michael Hensley, Professor Phil Hansbro, Professor Joerg Mattes, Professor Alistair Sim, Conjoint Professor Peter Wark
Scheme Priority Research Centre
Role Investigator
Funding Start 2006
Funding Finish 2013
GNo G0186914
Type Of Funding Internal
Category INTE
UON Y

Investigation of the association between chlamydial infection and asthma in different age groups$362,625

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Conjoint Professor Kenneth Beagley, Conjoint Professor Peter Gibson
Scheme Project Grant
Role Lead
Funding Start 2006
Funding Finish 2008
GNo G0185145
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Surveillance and Analysis of Avian Influenza Viruses in Migratory Birds in Australia$249,625

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Phil Hansbro, Dr Ian Barr, Conjoint Professor Peter Wark, Dr Paul Selleck, Dr Simone Warner, Laureate Professor Paul Foster, Dr Aeron Hurt, Dr Irene Peroulis, Dr John Curran, Conjoint Professor Peter Gibson
Scheme Potential Avian Influenza-Induced Pandemic
Role Lead
Funding Start 2006
Funding Finish 2006
GNo G0186000
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

The Newcastle Asthma Meeting (NAMe)$210,000

Funding body: Astra Zeneca

Funding body Astra Zeneca
Project Team

Phil hansbro

Scheme Conference support
Role Lead
Funding Start 2006
Funding Finish 2007
GNo
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON N

Characterisation of novel immune signals as targets for the treatment of asthma$160,000

Funding body: Commonwealth serum laboratories

Funding body Commonwealth serum laboratories
Project Team

Paul Foster

Scheme Unknown
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON N

Priority Research Centre for Asthma and Respiratory Disease$120,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team

Paul Foster/Peter Gibson

Scheme PRC
Role Investigator
Funding Start 2006
Funding Finish 2007
GNo
Type Of Funding Internal
Category INTE
UON N

Development of mouse models of angiogenesis$115,000

Funding body: CRC for Asthma and Airways

Funding body CRC for Asthma and Airways
Project Team

Phil Hansbro

Scheme Research Scholars Award
Role Lead
Funding Start 2006
Funding Finish 2007
GNo
Type Of Funding Internal
Category INTE
UON N

Prevention of heart disease by pneumococcal vaccination$55,000

Funding body: CVL - Pfiser

Funding body CVL - Pfiser
Project Team

Phil Hansbro

Scheme Unknown
Role Lead
Funding Start 2006
Funding Finish 2007
GNo
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON N

Surveillance for avian influenza viruses in wild birds in Australia$50,000

Funding body: Perpetual Limited

Funding body Perpetual Limited
Project Team Professor Phil Hansbro
Scheme Charitable Trusts and Foundations Project
Role Lead
Funding Start 2006
Funding Finish 2006
GNo G0186511
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Surveillance of microbial carriage by different feeding guilds of birds$30,000

Research council of SE Sweden & Swedish council for forestry & agriculture

Funding body: Research council of SE Sweden & Swedish council for forestry & agriculture

Funding body Research council of SE Sweden & Swedish council for forestry & agriculture
Project Team

Bjorn Olsen

Scheme Research council of SE Sweden & Swedish council for forestry & agriculture
Role Lead
Funding Start 2006
Funding Finish 2006
GNo
Type Of Funding International - Non Competitive
Category 3IFB
UON N

Identification of early-life signals induced in response to infection that predispose to asthma in later life$20,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Conjoint Professor Kenneth Beagley, Professor Alistair Sim
Scheme Pilot Grant
Role Lead
Funding Start 2006
Funding Finish 2006
GNo G0186699
Type Of Funding Internal
Category INTE
UON Y

Characterisation of chronic bacterial colonisation and the innate immune response in patients with neutrophilic asthma.$20,000

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team

Melanie Kenyon

Scheme Research Scholars Award
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo
Type Of Funding Other Public Sector - State
Category 2OPS
UON N

Characterisation of chronic bacterial colonisation and innate immune response in patients with neutrophilic Asthma$18,837

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Mrs Melanie Forster, Professor Phil Hansbro
Scheme PhD Scholarships
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo G0185993
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

-80¿C freezer$18,000

Funding body: Faculty of Health

Funding body Faculty of Health
Project Team

Phil hansbro

Scheme RIBG
Role Lead
Funding Start 2006
Funding Finish 2006
GNo
Type Of Funding Internal
Category INTE
UON N

American Thoracijavascript:closeProject();c Society 19-24 th of may 2006$2,400

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2006
Funding Finish 2006
GNo G0186495
Type Of Funding Internal
Category INTE
UON Y

200512 grants / $2,758,219

Drug targets from new animal models$2,030,948

Funding body: CRC for Asthma

Funding body CRC for Asthma
Project Team Laureate Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Ming Yang, Dr Simon Phipps
Scheme Research Grant
Role Investigator
Funding Start 2005
Funding Finish 2011
GNo G0185860
Type Of Funding CRC - Cooperative Research Centre
Category 4CRC
UON Y

Viruses, Infection/Immunology, vaccines and Asthma, Hunter medical Research Institute$321,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team

Ken Beagley

Scheme Research Infrastructure
Role Investigator
Funding Start 2005
Funding Finish 2007
GNo
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON N

CD4 T cell programming by neonatal and early-life infection$250,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Laureate Professor Paul Foster, Conjoint Professor Kenneth Beagley, Professor Phil Hansbro
Scheme Discovery Projects
Role Investigator
Funding Start 2005
Funding Finish 2007
GNo G0184398
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Modulation of inflammatory responses in the asthmatic lung by Chlamydial infection$50,000

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Conjoint Professor Kenneth Beagley
Scheme Research Grant
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0185208
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

Flexivent complete system solution for measurement of lung function$25,000

Funding body: Ramaciotti Foundations

Funding body Ramaciotti Foundations
Project Team Professor Phil Hansbro
Scheme Major Equipment Award
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0185625
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

2005 RIBG allocation$23,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Research Infrastructure Block Grant (RIBG)
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0185803
Type Of Funding Internal
Category INTE
UON Y

CD4 T cell programming by neonatal and early life infection$18,837

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Professor Phil Hansbro
Scheme PhD Scholarships
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0184978
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

Chlamydia infection of dendritic cells drives the development of pro-asthmatic Th2 cells$15,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team

Beagley KW

Scheme Unknown
Role Investigator
Funding Start 2005
Funding Finish 2005
GNo
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON N

Prevention of asthma by immunisation with pneumococcal cell walls$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Conjoint Professor Kenneth Beagley, Conjoint Professor Peter Gibson
Scheme Project Grant
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0184712
Type Of Funding Internal
Category INTE
UON Y

Efficacy of anti-microbial strategies$7,275

Funding body: Whiteley Corporation Pty Ltd

Funding body Whiteley Corporation Pty Ltd
Project Team Professor Phil Hansbro
Scheme Student Support Project
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0186017
Type Of Funding Not Known
Category UNKN
UON Y

The effect of maternal infection on predisposition towards asthma in adulthood$6,029

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Deborah Hodgson, Conjoint Associate Professor Vicki Clifton, Professor Phil Hansbro
Scheme Project Grant
Role Investigator
Funding Start 2005
Funding Finish 2005
GNo G0184735
Type Of Funding Internal
Category INTE
UON Y

World Inflammation Conference, 20-24 August 2005$1,130

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0185614
Type Of Funding Internal
Category INTE
UON Y

20046 grants / $124,300

Modulation of Asthma by bacterial infection or vaccination in different age groups$60,000

Funding body: Rebecca L Cooper Medical Research Foundation Ltd

Funding body Rebecca L Cooper Medical Research Foundation Ltd
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Conjoint Professor Kenneth Beagley
Scheme Research Grant
Role Lead
Funding Start 2004
Funding Finish 2006
GNo G0184154
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

ELISA reader/Fluorimeter/Luminometer$31,900

Funding body: Faculty of Health

Funding body Faculty of Health
Project Team

Darren Shafren

Scheme RIBG
Role Investigator
Funding Start 2004
Funding Finish 2004
GNo
Type Of Funding Internal
Category INTE
UON N

Modulation of immune responses in asthma by bacterial infections during early life.$15,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro, Laureate Professor Paul Foster, Conjoint Professor Peter Gibson
Scheme Project Grant
Role Lead
Funding Start 2004
Funding Finish 2004
GNo G0183512
Type Of Funding Internal
Category INTE
UON Y

The effect of maternal inflammation on fetal development, placental function and neonatal immune competence: An animal model of asthma during pregnancy$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Deborah Hodgson, Conjoint Associate Professor Vicki Clifton, Professor Phil Hansbro
Scheme Project Grant
Role Investigator
Funding Start 2004
Funding Finish 2004
GNo G0183352
Type Of Funding Internal
Category INTE
UON Y

Modulation of asthma by chlamydial infection at different ages$5,000

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Doctor Jay Horvat, Professor Phil Hansbro, Conjoint Professor Kenneth Beagley
Scheme PhD Scholarships
Role Investigator
Funding Start 2004
Funding Finish 2004
GNo G0183717
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

International Symposium on the Pneumococcus & Pneumococcal Diseases, 9-13 May 2004$2,400

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2004
Funding Finish 2004
GNo G0183956
Type Of Funding Internal
Category INTE
UON Y

20034 grants / $404,000

Viruses, Infection/Immunology, vaccines and Asthma, Hunter medical Research Institute$321,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team

Ken Beagley

Scheme Research Infrastructure
Role Investigator
Funding Start 2003
Funding Finish 2005
GNo
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON N

Modulation of immune responses in the asthmatic lung by bacterial infections.$50,000

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Professor Phil Hansbro, Conjoint Professor Peter Gibson, Conjoint Professor Kenneth Beagley, Dr Paul Foster
Scheme Research Grant
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0183600
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

Treatment of asthma by vaccination with bacterial antigens.$17,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Phil Hansbro, Conjoint Professor Peter Gibson, Conjoint Professor Kenneth Beagley
Scheme Research Grant
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0182627
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Prevention and treatment of asthma by immunisation with bacterial vaccines.$16,000

Funding body: Rebecca L Cooper Medical Research Foundation Ltd

Funding body Rebecca L Cooper Medical Research Foundation Ltd
Project Team Professor Phil Hansbro
Scheme Research Grant
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0183365
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

20027 grants / $113,309

Refrigerated Microfuge & Ultracentrifuge Buckets$40,967

Funding body: Faculty of Medicine and Health Sciences

Funding body Faculty of Medicine and Health Sciences
Project Team

Darren Shafren

Scheme RIBG
Role Investigator
Funding Start 2002
Funding Finish 2002
GNo
Type Of Funding Internal
Category INTE
UON N

Modulation of inflammatory responses in the asthmatic lung by bacterial infection and vaccination.$24,842

Funding body: Asthma Foundation of New South Wales

Funding body Asthma Foundation of New South Wales
Project Team Ms Julie Preston, Conjoint Professor Peter Gibson, Professor Phil Hansbro
Scheme PhD Scholarships
Role Investigator
Funding Start 2002
Funding Finish 2004
GNo G0181606
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

Development of new and improved pneumococcal vaccines.$16,000

Funding body: Rebecca L Cooper Medical Research Foundation Ltd

Funding body Rebecca L Cooper Medical Research Foundation Ltd
Project Team Professor Phil Hansbro
Scheme Research Grant
Role Lead
Funding Start 2002
Funding Finish 2002
GNo G0181997
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

Treatment of asthma by vaccination with bacterial antigens$12,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro, Conjoint Professor Peter Gibson, Conjoint Professor Kenneth Beagley
Scheme Project Grant
Role Lead
Funding Start 2002
Funding Finish 2002
GNo G0181356
Type Of Funding Internal
Category INTE
UON Y

PCR machine$10,000

Funding body: Faculty of Health

Funding body Faculty of Health
Project Team

Darren Shafren

Scheme Equipment grant
Role Investigator
Funding Start 2002
Funding Finish 2002
GNo
Type Of Funding Internal
Category INTE
UON N

Treatment of asthma by vaccination with bacterial antigens$7,000

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team

P G Gibson

Scheme Research Award
Role Investigator
Funding Start 2002
Funding Finish 2002
GNo
Type Of Funding Other Public Sector - Local
Category 2OPL
UON N

International Symposium on the Pneumococcus and Pneumococcal Diseases Anchorage, Alaska, 5 - 9 May, 2002$2,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2002
Funding Finish 2002
GNo G0181730
Type Of Funding Internal
Category INTE
UON Y

20017 grants / $323,811

Development of new generation vaccines including DNA vaccines, for mucosal disease Eg respiratory and reproductive tract infection$210,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team

Ken Beagley

Scheme Research Infrastructure
Role Investigator
Funding Start 2001
Funding Finish 2003
GNo
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON N

Development of an Elisa-based detection system for Listeria spp. and Listeria monocytogenes utilizing recombinant antibodies$45,000

Funding body: Tecra International Pty Ltd

Funding body Tecra International Pty Ltd
Project Team Professor Phil Hansbro, Associate Professor Darren Shafren
Scheme University Grant Partner Funding
Role Lead
Funding Start 2001
Funding Finish 2003
GNo G0181526
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Animal technician$38,045

Funding body: Faculty of Medicine and Health Sciences

Funding body Faculty of Medicine and Health Sciences
Project Team

Ken Beagley

Scheme RIBG
Role Investigator
Funding Start 2001
Funding Finish 2001
GNo
Type Of Funding Internal
Category INTE
UON N

Development of new and improved Pneumococcal vaccines.$12,000

Funding body: Ramaciotti Foundations

Funding body Ramaciotti Foundations
Project Team Professor Phil Hansbro
Scheme Research Grant
Role Lead
Funding Start 2001
Funding Finish 2001
GNo G0180651
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

Development of an Elisa-based detection system for Listeria spp. and Listeria monocytogenes utilizing recombinant antibodies$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro, Associate Professor Darren Shafren
Scheme Collaborative Research Grant
Role Lead
Funding Start 2001
Funding Finish 2001
GNo G0181525
Type Of Funding Internal
Category INTE
UON Y

Effects of infections by Streptococcus pneumoniae on eosinophilic immune responses$7,000

Funding body: John Hunter Hospital

Funding body John Hunter Hospital
Project Team

P M Hansbro

Scheme Respiratory SP&T Research Funds
Role Lead
Funding Start 2001
Funding Finish 2001
GNo
Type Of Funding Scheme excluded from IGS
Category EXCL
UON N

American Society for Microbiology, USA 20-24 May 2001$1,766

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2001
Funding Finish 2001
GNo G0180835
Type Of Funding Internal
Category INTE
UON Y

20005 grants / $209,122

Gene Pulser II Electroporator$160,000

Funding body: Faculty of Medicine and Health Sciences

Funding body Faculty of Medicine and Health Sciences
Project Team

Phil hansbro

Scheme Equipment grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo
Type Of Funding Internal
Category INTE
UON N

Gel Doc 2000 UV Flourescent Gel Documentation System$21,522

Funding body: Faculty of Medicine and Health Sciences

Funding body Faculty of Medicine and Health Sciences
Project Team

Phil Hansbro

Scheme Equipment grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo
Type Of Funding Internal
Category INTE
UON N

Development of new and improved pneumococcal vaccines$15,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team

P M Hansbro

Scheme Establishment grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo
Type Of Funding Scheme excluded from IGS
Category EXCL
UON N

Investigation of potential pneumococcal vaccine candidate antigens.$12,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme New Staff Grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo G0179329
Type Of Funding Internal
Category INTE
UON Y

Joint Annual Scientific Meeting & Exhibition of the Australian Society for Microbiology, Cairns QLD.$600

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Phil Hansbro
Scheme Travel Grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo G0180224
Type Of Funding Internal
Category INTE
UON Y
Edit

Research Supervision

Number of supervisions

Completed26
Current30

Total current UON EFTSL

PhD9.85

Current Supervision

Commenced Level of Study Research Title / Program / Supervisor Type
2015 PhD Fatty Acids and Bronchodilator Responses
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2015 PhD Neuropathological Effects of Putative Modifiers of Alzheimer's Disease Risk and Progression: Investigation in Mouse Models
PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2015 PhD Contribution of Cell Death to the Pathogenesis of Chronic Obstructive Pulmonary Disease (COPD)
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2015 PhD Investigation of Novel Immune Molecules in the Pathogenesis of Female Chlamydia Genital Tract Infections
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2015 PhD To assess the role of IFNe in modulating innate immune responses and protecting against Chlamydia infection in human tissues
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2015 PhD Generational Effects of Smoking in Pregnancy
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2015 PhD Novel Strategies to Treat Reproductive Tract Infection and Subsequent Infertility
PhD (Medical Biochemistry), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2014 PhD Utilisation of Microbial Products as New Therapies for COPD/Emphysema
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2014 PhD Chronic Obstructive Pulmonary Disease (COPD)
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2014 PhD Investigating the inter-relationship between iron, infection and immunity in the pathogenesis of lung disease
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2013 PhD The Role of the PI3K Signalling Pathway in the Innate Antiviral Response of Airway Epithelial Cells
PhD (Medicine), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2013 PhD Role of TLR/IL-13/STAT6/PI3K Response in Early-life Respiratory Infection and Infection-Induced Chronic Lung Disease
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2013 PhD Elucidating the Mechanisms of Infection-Induced, Steroid-Resistant Asthma
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2013 PhD Investigation of the pathogenesis and potential therapeutic interventions of influenza in Asthma and COPD
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2012 PhD Investigating the Mechanisms of Tobacco Cigarette Smoke-Induced Lung Cancer
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2012 PhD Roles of Bromodomain and extra terminal (BET) proteins in Suppression of Airway Inflammation
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2012 PhD Understanding the mechanisms of airway hyper-responsiveness in a mouse model of asthma
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2012 PhD Assessing the Epigenetic Involvement in the Development and Progression of Chronic Obstructive Pulmonary Disease (COPD)
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2011 PhD The Role of Interferon Epsilon in Protection Against Chlamydial Reproductive Tract Infections
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2011 PhD Mechanisms of Predisposition to Secondary Bacterial Pneumonia
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2011 PhD The Role of Innate Cells in Infectious Exacerbation of COPD
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2011 PhD Investigation of Pathogenesis of Chronic Obstructive Pulmonary Disease
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2011 PhD Immunoregulatory Therapies for Inflammatory Diseases
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2011 PhD Role of Fibulin-1 in the Pathogenesis of Chronic Pulmonary Diseases
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2011 PhD Mechanisms of Lung Inflammation Associated with Inflammatory Bowel Disease
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2010 PhD Indentification of New Therapeutics in COPD/ Emphysema
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2007 Honours Chlamydia and asthma II
Microbiology, University of Newcastle
Co-Supervisor
2007 Honours Chlamydia and asthma
Microbiology, University of Newcastle
Principal Supervisor
2007 PhD Rhinoviruses and asthma
Microbiology, University of Newcastle
Co-Supervisor
2006 PhD Investigation of fatty acid binding proteins and asthma
Microbiology, University of Sydney
Co-Supervisor

Past Supervision

Year Level of Study Research Title / Program / Supervisor Type
2015 PhD Investigation of the Mechanisms of Respiratory Infection- Induced Lung Disease
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2015 PhD Characterising Innate Immune Responses and the Role of PD-1 in Patients with COPD
PhD (Medicine), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2015 PhD Mechanisms of Increased Susceptibility to Influenza Infection in Mouse Models of Chronic Lung Diseases
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2014 PhD Immune Mechanisms that Underpin Early-Life Chlamydia Respiratory Infection-Induced Chronic Lung Disease
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2014 PhD The Role of microRNAs in Allergic Airways Disease and T Cell Biology
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2014 PhD The Role of MicroRNA in Regulating Anti-Bacterial Responses in Innate Immune Cells
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2013 PhD The Role of Early Life Infection on the Programming of CD4+ T-cells
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2012 PhD Modulation of Responses in Allergic Airways Disease by Haemophilus Influenzae Infection
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2012 PhD The Distribution, Abundance and Conservation of Avian Biodiversity in Yellow Sea Habitats in the Republic of Korea
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2011 PhD The Innate Immune Mechanisms Underlying the Interplay Between Respiratory Infections and Asthma
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2011 PhD A Streptococcus pneumoniae-based Immunoregulatory Therapy for Asthma
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2010 PhD Mechanism of Infection of Bronchial Epithelial Cells by Human and Avian Influenza Viruses
PhD (Medicine), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2009 PhD Nutritional Modulation of Lung Inflammation
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2008 PhD Modulation of Responses in the Asthmatic Lung by Chlamydial Infection
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2007 Honours campylobacter carriage in birds
Microbiology, University of Newcastle
Principal Supervisor
2007 PhD Prevention and treatment of asthma using pneumococcal infection
Microbiology, University of Newcastle
Co-Supervisor
2007 PhD Modulation of Responses in the Asthmatic Lung by Streptococcus Pneumoniae
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2006 PhD Investigation of Surface Components of Listeria spp. by Phage Display
PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2006 Honours Association of Haemophilus influenzae infection and asthma
Accounting, University of Newcastle
Principal Supervisor
2006 Honours Interaction of chlamydia with NOD proteins
Accounting, University of Newcastle
Co-Supervisor
2006 Honours Rhinoviruses and asthma
Microbiology, University of Newcastle
Co-Supervisor
2003 Honours Association of Chlamydia infection and asthma
Accounting, University of Newcastle
Principal Supervisor
2003 Honours Chlamydia in teh reproductive tract
Microbiology, University of Newcastle
Co-Supervisor
2001 Honours HIV infcetions
Microbiology, University of Newcastle
Co-Supervisor
2001 PhD Identification of novel surface proteins of Streptococcus pneumoniae
Microbiology, Unknown
Principal Supervisor
2001 Honours Prevention of asthma by pneumococcal infection
Microbiology, University of Newcastle
Principal Supervisor
Edit

Research Projects

Humira and Endothelial Function in Rheumatoid Arthritis 2 (HEART RA - 2) 2015 -

Hunter HEART-RA will answer many questions regarding cardiovascular disease in ACPA-positive RA. However, it will not evaluate ACPA-negative RA patient group and cannot answer the question of when, at which stage in the development of RA, cardiovascular risk becomes elevated and which inflammatory and non-inflammatory processes may be responsible. Hunter HEAT-RA-2 has been designed to investigate these questions in greater detail. 

Hunter HEART-RA-2 is an extension of Hunter HEART-RA consisting of 2 parts.

Part 1: Randomised Controlled Trial evaluating the Effect of the TNF-Inhibitor drug Humira (adalimumab) upon cardiovascular risk as measured by a platform of cardiovascular assessments. This second study will include ACPA-negative RA patients and more comprehensive assessments of cardiovascular function and inflammatory burden.

Part 2: Cross-Sectional Study evaluating cardiovascular risk in First Degree Relatives of patients with Rheumatoid Arthritis, Healthy Unrelated Controls and people with immunological markers of rheumatoid arthritis without clinical disease.  

In both parts of this study there will be a platform of assessments of articular inflammation, cardiovascular function and laboratory assessments. In addition to the routine assessments of inflammatory burden (clinical joint counts, ESR and CRP) musculoskeletal ultrasound will be used to detect subclinical joint inflammation.  The platform of cardiovascular assessments include endothelial function (EndoPAT), central arterial pressure indices, aortic stiffness (carotid-femoral pulse wave velocity) and carotid ultrasound (carotid intimal medial thickness and carotid plaque measurement). Participants will have a range of genetic and immunological tests and a sub-group will participate in studies of NETosis. 

Grants

Humira and Endothelial Function in Rheumatoid Arthritis - 2 (HEART-RA-2)

Funding body: Abbvie Pharmaceuticals

Funding body Abbvie Pharmaceuticals
Description

Interim analysis in Hunter HEART-RA-1 confirmed that endothelial function correlates inversely with inflammatory burden in patients with anti-CCP positive rheumatoid arthritis (RA). However, it appears that other disease-specific but non-inflammatory mechanisms may contribute to cardiovascular disease in RA. This might include genetic factors, abnormalities of lipid transport and newly described immune mechanisms such as NETosis. HEART-RA-1 also only evaluated patients with anti-CCP positive RA. 

HEART-RA-2 will consist of 2 parts:

Part 1, a randomised controlled trial will evaluate the effect of Humira upon endothelial function in anti-CCP antibody positive and anti-CCP antibody negative patients with RA. 

Part 2 will evaluate non-inflammatory mechanisms of cardiovascular disease by taking inflammation out of the equation. This will be done by studying people with Pre-RA i.e. who have evidence of RA on blood test of on ultrasound but no clinical evidence of RA.

Scheme Abbvie Investigator-Initiated Grant

Collaborators

Name Organisation
Professor John Richard Attia University of Newcastle
Professor Phil Michael Hansbro University of Newcastle

Edit

Research Collaborations

The map is a representation of a researchers co-authorship with collaborators across the globe. The map displays the number of publications against a country, where there is at least one co-author based in that country. Data is sourced from the University of Newcastle research publication management system (NURO) and may not fully represent the authors complete body of work.

Country Count of Publications
Australia 181
United States 23
United Kingdom 16
Canada 14
Japan 8
More...
Edit

News

PhD Scholarship - Elucidating and targeting genomic and epigenetic changes in the development and progression of lung cancer

June 24, 2016

A PhD scholarship is available for a student to investigate Elucidating and targeting genomic and epigenetic changes in the development and progression of lung cancer under the supervision of Professor Phil Hansbro.

Professor Phil Hansbro

Protein implicated as key and common cause in respiratory illness

June 23, 2016

Hunter researchers have discovered a protein that induces both stiffening and inflammation in the airways of the lung, causing severe and chronic respiratory illness.

NHMRC

NHMRC funding success 2016

November 9, 2015

Professor Phil Hansbro has been awarded more than $720,000 in NHMRC Project Grant funding commencing in 2016 for his research project Role and potential for therapeutic targeting of dysfunction, oxidative stress and altered metabolism in mitochondria in the pathogenesis of COPD.

Phil Hansbro in the Newcastle Herald

Newcastle Herald: Research links gut bacteria, disease treatment

September 21, 2015

A NEWCASTLE research team that's used mice poo to treat asthmatic mice could be first in the world to show a link between gut bacteria and diseases throughout the body.

Australian Research Council (ARC)

ARC Discovery Project funding success

November 19, 2014

Professor Phil Hansbro has been awarded more than $443,000 in ARC Discovery Project funding commencing in 2015 for his research project Elucidating the post-transcriptional regulation of mast cell proteases.

Modifying epigenetics as a novel treatment in COPD

NHMRC funding success

November 18, 2014

Professor Phil Hansbro and his team have been awarded over $1 million from the NHMRC to investigate modifying epigenetics as a novel treatment in COPD.

Professor Phil Hansbro

UON researcher awarded NHMRC Fellowship

September 2, 2014

UON researcher Professor Phil Hansbro has received a highly competitive NHMRC Principal Research Fellowship for a project titled Development of new therapies for respiratory diseases and infection.

‘transpoosion’ for a healthy gut

‘transpoosion’ for a healthy gut

August 25, 2014

Professor Phil Hansbro's research on the devastating lung disease emphysema, and the role of the microbiome in the gut in this disease, was featured on the ABC's Catalyst program.

Asthma discovery

Respiratory disease breakthrough

July 1, 2014

Sinister specks of a molecule known as ASC are escaping from cells then coursing through the body to exacerbate the biological inflammatory response in major airway diseases such as asthma and emphysema.

Phil Hansbro

HMRI 2013 Awards Night

November 7, 2013

Respiratory researcher Professor Phil Hansbro won the prestigious 2013 Award for Research Excellence tonight as more than $1.4 million in grant funding was awarded and acknowledged in the Hunter Medical Research Institute's 2013 Awards Night.

HMRI logo

Newcastle researchers help in fight against STDs

March 1, 2013

Newcastle researchers have contributed to the discovery of a protein in the female reproductive tract that protects against sexually transmitted diseases (STDs) such as chlamydia and herpes simplex virus (HSV).

Professor Phil Hansbro

Position

Professor, NHMRC Fellow and Brawn Fellow
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine

Focus area

Immunology and Microbiology

Contact Details

Email philip.hansbro@newcastle.edu.au
Phone (02) 4042 0187
Mobile 0427263084
Fax (02) 4042 0024

Office

Room HMRI 2406
Building HMRI Building
Location HMRI Building

,
Edit